Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

ABSTRACT This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he described accurately and what he missed from today's perspective. Parkinson's disease today is understood as a multietiologi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Movement disorders Jg. 32; H. 9; S. 1264 - 1310
Hauptverfasser: Obeso, J.A., Stamelou, M., Goetz, C.G., Poewe, W., Lang, A.E., Weintraub, D., Burn, D., Halliday, G.M., Bezard, E., Przedborski, S., Lehericy, S., Brooks, D.J., Rothwell, J.C., Hallett, M., DeLong, M.R., Marras, C., Tanner, C.M., Ross, G.W., Langston, J.W., Klein, C., Bonifati, V., Jankovic, J., Lozano, A.M., Deuschl, G., Bergman, H., Tolosa, E., Rodriguez‐Violante, M., Fahn, S., Postuma, R.B., Berg, D., Marek, K., Standaert, D.G., Surmeier, D.J., Olanow, C.W., Kordower, J.H., Calabresi, P., Schapira, A.H.V., Stoessl, A.J.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Wiley Subscription Services, Inc 01.09.2017
Schlagworte:
200 years anniversary
Anniversaries and Special Events
History, 19th Century
History, 20th Century
History, 21st Century
Humans
Movement disorders
Neurodegenerative diseases
Paralysis
Parkinson Disease - history
Parkinson's disease
Shaking Palsy
Shaking Palsy
Parkinson's disease
200 years anniversary
ISSN:0885-3185, 1531-8257, 1531-8257
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract ABSTRACT This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he described accurately and what he missed from today's perspective. Parkinson's disease today is understood as a multietiological condition with uncertain etiopathogenesis. Many advances have occurred regarding pathophysiology and symptomatic treatments, but critically important issues are still pending resolution. Among the latter, the need to modify disease progression is undoubtedly a priority. In sum, this multiple‐author article, prepared to commemorate the bicentenary of the shaking palsy, provides a historical state‐of‐the‐art account of what has been achieved, the current situation, and how to progress toward resolving Parkinson's disease. © 2017 International Parkinson and Movement Disorder Society
AbstractList This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he described accurately and what he missed from today's perspective. Parkinson's disease today is understood as a multietiological condition with uncertain etiopathogenesis. Many advances have occurred regarding pathophysiology and symptomatic treatments, but critically important issues are still pending resolution. Among the latter, the need to modify disease progression is undoubtedly a priority. In sum, this multiple-author article, prepared to commemorate the bicentenary of the shaking palsy, provides a historical state-of-the-art account of what has been achieved, the current situation, and how to progress toward resolving Parkinson's disease. © 2017 International Parkinson and Movement Disorder Society
This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he described accurately and what he missed from today's perspective. Parkinson's disease today is understood as a multietiological condition with uncertain etiopathogenesis. Many advances have occurred regarding pathophysiology and symptomatic treatments, but critically important issues are still pending resolution. Among the latter, the need to modify disease progression is undoubtedly a priority. In sum, this multiple-author article, prepared to commemorate the bicentenary of the shaking palsy, provides a historical state-of-the-art account of what has been achieved, the current situation, and how to progress toward resolving Parkinson's disease. © 2017 International Parkinson and Movement Disorder Society.
This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he described accurately and what he missed from today's perspective. Parkinson's disease today is understood as a multietiological condition with uncertain etiopathogenesis. Many advances have occurred regarding pathophysiology and symptomatic treatments, but critically important issues are still pending resolution. Among the latter, the need to modify disease progression is undoubtedly a priority. In sum, this multiple-author article, prepared to commemorate the bicentenary of the shaking palsy, provides a historical state-of-the-art account of what has been achieved, the current situation, and how to progress toward resolving Parkinson's disease. © 2017 International Parkinson and Movement Disorder Society.This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he described accurately and what he missed from today's perspective. Parkinson's disease today is understood as a multietiological condition with uncertain etiopathogenesis. Many advances have occurred regarding pathophysiology and symptomatic treatments, but critically important issues are still pending resolution. Among the latter, the need to modify disease progression is undoubtedly a priority. In sum, this multiple-author article, prepared to commemorate the bicentenary of the shaking palsy, provides a historical state-of-the-art account of what has been achieved, the current situation, and how to progress toward resolving Parkinson's disease. © 2017 International Parkinson and Movement Disorder Society.
ABSTRACT This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he described accurately and what he missed from today's perspective. Parkinson's disease today is understood as a multietiological condition with uncertain etiopathogenesis. Many advances have occurred regarding pathophysiology and symptomatic treatments, but critically important issues are still pending resolution. Among the latter, the need to modify disease progression is undoubtedly a priority. In sum, this multiple‐author article, prepared to commemorate the bicentenary of the shaking palsy, provides a historical state‐of‐the‐art account of what has been achieved, the current situation, and how to progress toward resolving Parkinson's disease. © 2017 International Parkinson and Movement Disorder Society
This article reviews and summarizes 200 years of Parkinson’s disease. It comprises a relevant history of Dr. James Parkinson’s himself and what he described accurately and what he missed from today’s perspective. Parkinson’s disease today is understood as a multietiological condition with uncertain etiopathogenesis. Many advances have occurred regarding pathophysiology and symptomatic treatments, but critically important issues are still pending resolution. Among the latter, the need to modify disease progression is undoubtedly a priority. In sum, this multiple-author article, prepared to commemorate the bicentenary of the shaking palsy, provides a historical state-of-the-art account of what has been achieved, the current situation, and how to progress toward resolving Parkinson’s disease.
Author Halliday, G.M.
Weintraub, D.
Tanner, C.M.
Schapira, A.H.V.
Lang, A.E.
DeLong, M.R.
Jankovic, J.
Poewe, W.
Brooks, D.J.
Ross, G.W.
Rodriguez‐Violante, M.
Lozano, A.M.
Goetz, C.G.
Standaert, D.G.
Klein, C.
Postuma, R.B.
Lehericy, S.
Berg, D.
Olanow, C.W.
Bezard, E.
Hallett, M.
Stoessl, A.J.
Marek, K.
Marras, C.
Tolosa, E.
Deuschl, G.
Bergman, H.
Przedborski, S.
Kordower, J.H.
Obeso, J.A.
Surmeier, D.J.
Stamelou, M.
Fahn, S.
Calabresi, P.
Burn, D.
Bonifati, V.
Rothwell, J.C.
Langston, J.W.
AuthorAffiliation 27 Movement Disorders and Neuromodulation Center, Department of Neurology, University of California–San Francisco, San Francisco, California, USA
33 Parkinson’s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
2 Universidad CEU San Pablo, Madrid, Spain
10 Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
14 School of Medical Sciences, University of New South Wales and Neuroscience Research Australia, Sydney, Australia
16 China Academy of Medical Sciences, Institute of Lab Animal Sciences, Beijing, China
41 Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico
47 Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA
38 Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel
29 Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA
22 Department of Nucl
AuthorAffiliation_xml – name: 7 Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
– name: 25 Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA
– name: 38 Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel
– name: 54 University Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK
– name: 45 Klinikfür Neurologie, UKSH, Campus Kiel, Christian-Albrechts-Universität, Kiel, Germany
– name: 22 Department of Nuclear Medicine, Aarhus University, Aarhus, Denmark
– name: 36 Department of Medical Neurobiology, Institute of Medical Research Israel-Canada, Jerusalem, Israel
– name: 50 Research Center for Brain Repair, Rush University Medical Center, Chicago, Illinois, USA
– name: 19 Institut du Cerveau et de la Moelle épinière – ICM, Centre de NeuroImagerie de Recherche – CENIR, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France
– name: 37 Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel
– name: 10 Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
– name: 48 Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
– name: 47 Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA
– name: 43 Department of Neurology, Columbia University Medical Center, New York, New York, USA
– name: 49 Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA
– name: 27 Movement Disorders and Neuromodulation Center, Department of Neurology, University of California–San Francisco, San Francisco, California, USA
– name: 12 Medical Sciences, Newcastle University, Newcastle, UK
– name: 4 Department of Neurology, Philipps University, Marburg, Germany
– name: 41 Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico
– name: 13 Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia
– name: 5 Parkinson’s Disease and Movement Disorders Department, HYGEIA Hospital and Attikon Hospital, University of Athens, Athens, Greece
– name: 24 Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
– name: 29 Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA
– name: 28 Parkinson’s Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA
– name: 14 School of Medical Sciences, University of New South Wales and Neuroscience Research Australia, Sydney, Australia
– name: 8 Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson’s Disease, Toronto Western Hospital, Toronto, Canada
– name: 53 Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, Rome, Italy
– name: 15 Université de Bordeaux, Institut des Maladies Neurodégénératives, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France
– name: 46 Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA
– name: 52 Neurological Clinic, Department of Medicine, Hospital Santa Maria della Misericordia, University of Perugia, Perugia, Italy
– name: 34 Department of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Canada
– name: 6 Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
– name: 16 China Academy of Medical Sciences, Institute of Lab Animal Sciences, Beijing, China
– name: 21 Clinical Sciences Department, Newcastle University, Newcastle, UK
– name: 32 Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands
– name: 1 HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles, Madrid, Spain
– name: 44 Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada
– name: 2 Universidad CEU San Pablo, Madrid, Spain
– name: 11 Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Corporal Michael J. Crescenz Veteran’s Affairs Medical Center, Philadelphia, Pennsylvania, USA
– name: 33 Parkinson’s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
– name: 30 Parkinson’s Institute, Sunnyvale, California, USA
– name: 55 Pacific Parkinson’s Research Centre, Division of Neurology & Djavadf Mowafaghian Centre for Brain Health, University of British Columbia, British Columbia, Canada
– name: 39 Parkinson’s Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Barcelona, Spain
– name: 18 Columbia Translational Neuroscience Initiative, Columbia University, New York, New York, USA
– name: 56 Vancouver Coastal Health, Vancouver, British Columbia, Canada
– name: 26 Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson’s disease, Toronto Western Hospital, University of Toronto, Toronto, Canada
– name: 40 Department of Medicine, Universitat de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain
– name: 42 Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico
– name: 35 Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian Albrechts University Kiel, Kiel, Germany
– name: 3 CIBERNED, Madrid, Spain
– name: 20 Groupe Hospitalier Pitié-Salpêtrière, Paris, France
– name: 17 Departments of Neurology, Pathology, and Cell Biology, the Center for Motor Neuron Biology and Disease, Columbia University, New York, New York, USA
– name: 23 Human Neurophysiology, Sobell Department, UCL Institute of Neurology, London, UK
– name: 51 Neuroscience Graduate Program, Rush University Medical Center, Chicago, Illinois, USA
– name: 9 Department of Medicine, University of Toronto, Toronto, Canada
– name: 31 Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
Author_xml – sequence: 1
  givenname: J.A.
  surname: Obeso
  fullname: Obeso, J.A.
  email: jaobeso@movementdisorders.org
  organization: CIBERNED
– sequence: 2
  givenname: M.
  orcidid: 0000-0003-1668-9925
  surname: Stamelou
  fullname: Stamelou, M.
  organization: University of Athens
– sequence: 3
  givenname: C.G.
  surname: Goetz
  fullname: Goetz, C.G.
  organization: Rush University Medical Center
– sequence: 4
  givenname: W.
  surname: Poewe
  fullname: Poewe, W.
  organization: Medical University Innsbruck
– sequence: 5
  givenname: A.E.
  surname: Lang
  fullname: Lang, A.E.
  organization: University of Toronto
– sequence: 6
  givenname: D.
  surname: Weintraub
  fullname: Weintraub, D.
  organization: Corporal Michael J. Crescenz Veteran's Affairs Medical Center
– sequence: 7
  givenname: D.
  surname: Burn
  fullname: Burn, D.
  organization: Newcastle University
– sequence: 8
  givenname: G.M.
  orcidid: 0000-0003-0422-8398
  surname: Halliday
  fullname: Halliday, G.M.
  organization: University of New South Wales and Neuroscience Research Australia
– sequence: 9
  givenname: E.
  surname: Bezard
  fullname: Bezard, E.
  organization: Institute of Lab Animal Sciences
– sequence: 10
  givenname: S.
  surname: Przedborski
  fullname: Przedborski, S.
  organization: Columbia University
– sequence: 11
  givenname: S.
  surname: Lehericy
  fullname: Lehericy, S.
  organization: Groupe Hospitalier Pitié‐Salpêtrière
– sequence: 12
  givenname: D.J.
  surname: Brooks
  fullname: Brooks, D.J.
  organization: Aarhus University
– sequence: 13
  givenname: J.C.
  orcidid: 0000-0003-1367-6467
  surname: Rothwell
  fullname: Rothwell, J.C.
  organization: UCL Institute of Neurology
– sequence: 14
  givenname: M.
  surname: Hallett
  fullname: Hallett, M.
  organization: National Institutes of Health
– sequence: 15
  givenname: M.R.
  surname: DeLong
  fullname: DeLong, M.R.
  organization: Emory University School of Medicine
– sequence: 16
  givenname: C.
  surname: Marras
  fullname: Marras, C.
  organization: University of Toronto
– sequence: 17
  givenname: C.M.
  surname: Tanner
  fullname: Tanner, C.M.
  organization: San Francisco Veterans Affairs Medical Center
– sequence: 18
  givenname: G.W.
  surname: Ross
  fullname: Ross, G.W.
  organization: Veterans Affairs Pacific Islands Health Care System
– sequence: 19
  givenname: J.W.
  surname: Langston
  fullname: Langston, J.W.
  organization: Parkinson's Institute
– sequence: 20
  givenname: C.
  surname: Klein
  fullname: Klein, C.
  organization: University of Luebeck
– sequence: 21
  givenname: V.
  surname: Bonifati
  fullname: Bonifati, V.
  organization: Erasmus University Medical Center
– sequence: 22
  givenname: J.
  surname: Jankovic
  fullname: Jankovic, J.
  organization: Baylor College of Medicine
– sequence: 23
  givenname: A.M.
  surname: Lozano
  fullname: Lozano, A.M.
  organization: Toronto Western Hospital
– sequence: 24
  givenname: G.
  orcidid: 0000-0002-4176-9196
  surname: Deuschl
  fullname: Deuschl, G.
  organization: Christian Albrechts University Kiel
– sequence: 25
  givenname: H.
  surname: Bergman
  fullname: Bergman, H.
  organization: Hadassah University Hospital
– sequence: 26
  givenname: E.
  surname: Tolosa
  fullname: Tolosa, E.
  organization: Universitat de Barcelona
– sequence: 27
  givenname: M.
  orcidid: 0000-0002-6041-9941
  surname: Rodriguez‐Violante
  fullname: Rodriguez‐Violante, M.
  organization: Instituto Nacional de Neurología y Neurocirugía
– sequence: 28
  givenname: S.
  surname: Fahn
  fullname: Fahn, S.
  organization: Columbia University Medical Center
– sequence: 29
  givenname: R.B.
  surname: Postuma
  fullname: Postuma, R.B.
  organization: Montreal General Hospital
– sequence: 30
  givenname: D.
  surname: Berg
  fullname: Berg, D.
  organization: Christian‐Albrechts‐Universität
– sequence: 31
  givenname: K.
  surname: Marek
  fullname: Marek, K.
  organization: Institute for Neurodegenerative Disorders
– sequence: 32
  givenname: D.G.
  orcidid: 0000-0003-2921-8348
  surname: Standaert
  fullname: Standaert, D.G.
  organization: University of Alabama at Birmingham
– sequence: 33
  givenname: D.J.
  surname: Surmeier
  fullname: Surmeier, D.J.
  organization: Northwestern University
– sequence: 34
  givenname: C.W.
  surname: Olanow
  fullname: Olanow, C.W.
  organization: Mount Sinai School of Medicine
– sequence: 35
  givenname: J.H.
  surname: Kordower
  fullname: Kordower, J.H.
  organization: Rush University Medical Center
– sequence: 36
  givenname: P.
  surname: Calabresi
  fullname: Calabresi, P.
  organization: Santa Lucia Foundation, IRCCS
– sequence: 37
  givenname: A.H.V.
  surname: Schapira
  fullname: Schapira, A.H.V.
  organization: University College London
– sequence: 38
  givenname: A.J.
  surname: Stoessl
  fullname: Stoessl, A.J.
  organization: Vancouver Coastal Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28887905$$D View this record in MEDLINE/PubMed
BookMark eNp9kd9rFDEQx4NU7LX64D8gAR9UcNtkd7PJ-iAc9SdULFSfQzY76aXuJdfMbuX-e7O9WrSgTxOYz3yYyfeA7IUYgJCnnB1xxsrjdY9HpeRcPCALLipeqFLIPbJgSomi4krskwPES8YywptHZL9USsmWiQWJZwbH13STACHkhwk9ddM4JaDR0TOTfviAMbxA2nsEg_CGLiluwHozUEA0WxoDHVdAS8bGFV2G4K8hoUnbWTA3zlcmSy6ybMDtY_LQ5QpPbush-f7h_beTT8Xp14-fT5anhRWsFUVvoFO9qZSpmGrqpil763rZmrqtbCMda1tX9qLmTlhmuau7joOtuoo5ME666pC83Xk3U7eG3ubjkhn0Jvl1Xk1H4_XfneBX-iJea9EoIeomC17eClK8mgBHvfZoYRhMgDih5m0l81dLqTL6_B56GacU8nkz1Uglyxvhsz83ulvldxYZeLUDbIqICdwdwpmec9Y5Z32Tc2aP77HWj2b0cT7GD_-b-OkH2P5brb-8O99N_AL_tbmu
CitedBy_id crossref_primary_10_1042_EBC20200114
crossref_primary_10_1096_fj_202201605RR
crossref_primary_10_1016_j_jneumeth_2020_108741
crossref_primary_10_1016_j_gaitpost_2025_04_001
crossref_primary_10_1016_j_neuron_2018_07_028
crossref_primary_10_1126_scitranslmed_aau0713
crossref_primary_10_1016_j_parkreldis_2021_10_016
crossref_primary_10_3389_fneur_2019_01328
crossref_primary_10_1134_S000629792106002X
crossref_primary_10_3233_JPD_191835
crossref_primary_10_1002_mds_29369
crossref_primary_10_3390_cells8111407
crossref_primary_10_3390_nu15082007
crossref_primary_10_1016_j_neuint_2022_105344
crossref_primary_10_3390_brainsci12111579
crossref_primary_10_1007_s12264_021_00775_9
crossref_primary_10_1111_1460_6984_12824
crossref_primary_10_1016_j_archger_2024_105738
crossref_primary_10_2217_imt_2017_0146
crossref_primary_10_1007_s12035_022_03193_8
crossref_primary_10_1186_s13024_020_00367_7
crossref_primary_10_1016_j_ncl_2024_12_002
crossref_primary_10_1016_j_neuint_2020_104816
crossref_primary_10_1007_s10571_025_01595_5
crossref_primary_10_1002_mds_28145
crossref_primary_10_3389_fnagi_2018_00012
crossref_primary_10_1055_s_0043_1763508
crossref_primary_10_3389_fneur_2020_00395
crossref_primary_10_1038_nrneurol_2017_183
crossref_primary_10_1080_14737175_2019_1629290
crossref_primary_10_1093_brain_awae089
crossref_primary_10_1007_s40291_023_00668_9
crossref_primary_10_1152_jn_00307_2025
crossref_primary_10_1016_j_jneumeth_2018_03_006
crossref_primary_10_1111_jnc_14902
crossref_primary_10_1007_s00401_017_1788_5
crossref_primary_10_1016_j_apmr_2019_07_013
crossref_primary_10_1016_j_parkreldis_2025_107852
crossref_primary_10_3233_JPD_212876
crossref_primary_10_1016_j_omtm_2019_11_013
crossref_primary_10_1016_j_nbd_2019_104587
crossref_primary_10_3389_fnagi_2022_1065126
crossref_primary_10_3390_ijms231911054
crossref_primary_10_1016_j_dscb_2024_100143
crossref_primary_10_1016_j_parkreldis_2018_11_011
crossref_primary_10_1155_2019_7503230
crossref_primary_10_7554_eLife_90905_3
crossref_primary_10_1016_j_parkreldis_2025_107987
crossref_primary_10_1016_j_parkreldis_2021_11_021
crossref_primary_10_47419_bjbabs_v4i04_169
crossref_primary_10_3390_diagnostics12010112
crossref_primary_10_3233_JPD_230030
crossref_primary_10_3389_fnmol_2019_00252
crossref_primary_10_1227_neu_0000000000002274
crossref_primary_10_1007_s10548_023_01002_6
crossref_primary_10_1016_j_parkreldis_2021_09_016
crossref_primary_10_3233_JPD_201981
crossref_primary_10_1016_j_mehy_2020_110397
crossref_primary_10_1073_pnas_1922184117
crossref_primary_10_31083_j_fbl2802033
crossref_primary_10_1523_JNEUROSCI_1345_19_2019
crossref_primary_10_3390_molecules30081672
crossref_primary_10_1002_iub_2893
crossref_primary_10_1007_s12013_020_00957_8
crossref_primary_10_2196_39954
crossref_primary_10_3389_fnagi_2022_851135
crossref_primary_10_1186_s40168_020_00988_6
crossref_primary_10_1016_j_arr_2018_04_006
crossref_primary_10_1007_s12041_018_0960_6
crossref_primary_10_1016_j_arr_2017_12_007
crossref_primary_10_1016_j_nicl_2025_103834
crossref_primary_10_1016_j_bmcl_2018_11_054
crossref_primary_10_1080_19390211_2021_1922567
crossref_primary_10_3389_fgene_2017_00177
crossref_primary_10_1016_j_jneuroim_2025_578716
crossref_primary_10_1016_j_mcn_2020_103501
crossref_primary_10_1371_journal_pone_0268588
crossref_primary_10_1016_j_apnr_2019_151186
crossref_primary_10_1016_j_nbd_2018_06_008
crossref_primary_10_1002_iub_2304
crossref_primary_10_1016_j_mcna_2018_10_014
crossref_primary_10_3389_fnins_2023_1293847
crossref_primary_10_1016_j_envint_2023_108229
crossref_primary_10_1016_j_arr_2022_101636
crossref_primary_10_3389_fnsys_2021_747681
crossref_primary_10_3390_ijms22073381
crossref_primary_10_3390_cells14171340
crossref_primary_10_1016_j_tjnut_2022_11_006
crossref_primary_10_1080_14606925_2024_2405775
crossref_primary_10_3390_brainsci10090571
crossref_primary_10_3390_genes15020255
crossref_primary_10_1371_journal_pone_0255274
crossref_primary_10_1002_mds_29037
crossref_primary_10_2174_0115748855292178240223100534
crossref_primary_10_1017_wtc_2024_15
crossref_primary_10_1038_s41467_020_20041_2
crossref_primary_10_1515_revneuro_2020_0083
crossref_primary_10_3390_ijms252111490
crossref_primary_10_1038_nrd_2018_136
crossref_primary_10_3390_biom12030469
crossref_primary_10_3390_ijms25020707
crossref_primary_10_1089_pop_2020_0316
crossref_primary_10_1111_acel_13575
crossref_primary_10_1002_pmic_202300202
crossref_primary_10_1007_s10787_025_01672_7
crossref_primary_10_3389_fneur_2022_758452
crossref_primary_10_1038_s41598_021_89300_6
crossref_primary_10_3389_fgene_2020_590365
crossref_primary_10_3389_fncom_2024_1410335
crossref_primary_10_3389_fneur_2022_999820
crossref_primary_10_1111_cns_13429
crossref_primary_10_1177_1073858421991066
crossref_primary_10_1016_j_parkreldis_2025_107305
crossref_primary_10_1177_20592043231197792
crossref_primary_10_1007_s10787_025_01816_9
crossref_primary_10_3389_fnins_2019_00894
crossref_primary_10_3390_ijms23126808
crossref_primary_10_1016_j_ymthe_2019_08_005
crossref_primary_10_1111_acel_13101
crossref_primary_10_1186_s13024_021_00501_z
crossref_primary_10_1038_s41531_025_00927_y
crossref_primary_10_1007_s12640_019_00109_8
crossref_primary_10_22379_anc_v41i1_1861
crossref_primary_10_3389_fnins_2021_696440
crossref_primary_10_1007_s11011_021_00795_4
crossref_primary_10_1016_j_lfs_2020_118019
crossref_primary_10_3390_jcm12062334
crossref_primary_10_1186_s12916_024_03766_5
crossref_primary_10_3390_jcm13154539
crossref_primary_10_1007_s10072_022_06496_9
crossref_primary_10_4103_aian_aian_38_22
crossref_primary_10_1212_NXG_0000000000000271
crossref_primary_10_3389_fnins_2020_604150
crossref_primary_10_7554_eLife_46112
crossref_primary_10_1111_ejn_14952
crossref_primary_10_3390_ijms25168971
crossref_primary_10_3390_ijms22094341
crossref_primary_10_1186_s12934_020_01313_4
crossref_primary_10_1038_s41598_023_46576_0
crossref_primary_10_1007_s00018_025_05810_w
crossref_primary_10_1016_j_heliyon_2024_e34858
crossref_primary_10_2147_NDT_S532027
crossref_primary_10_3389_fresc_2022_819862
crossref_primary_10_3390_biomedicines9030295
crossref_primary_10_1016_j_jff_2021_104764
crossref_primary_10_3390_cells10113143
crossref_primary_10_1177_17590914231155976
crossref_primary_10_1186_s13024_021_00502_y
crossref_primary_10_3390_jcm9061941
crossref_primary_10_36290_neu_2020_016
crossref_primary_10_3389_fncir_2019_00050
crossref_primary_10_1016_j_arr_2021_101508
crossref_primary_10_7554_eLife_48408
crossref_primary_10_3390_chemosensors10060229
crossref_primary_10_3390_pharmaceutics15082035
crossref_primary_10_1016_j_heliyon_2024_e34823
crossref_primary_10_3389_fbioe_2022_855195
crossref_primary_10_1002_mds_27805
crossref_primary_10_3389_fnagi_2025_1590224
crossref_primary_10_1177_1535370220961788
crossref_primary_10_1016_j_bbr_2023_114561
crossref_primary_10_3390_ijms24032171
crossref_primary_10_3390_molecules25194382
crossref_primary_10_1002_jnr_25094
crossref_primary_10_3390_ijms222413488
crossref_primary_10_51581_rccm_v27i2_173
crossref_primary_10_1002_med_21987
crossref_primary_10_1186_s13041_024_01128_z
crossref_primary_10_1007_s12035_018_1419_8
crossref_primary_10_3389_fneur_2021_702502
crossref_primary_10_1093_brain_awz261
crossref_primary_10_1016_j_envint_2022_107528
crossref_primary_10_3390_nu15122775
crossref_primary_10_3389_fnagi_2019_00302
crossref_primary_10_3389_fneur_2021_792227
crossref_primary_10_3389_fcell_2022_903031
crossref_primary_10_3390_biomedicines9070812
crossref_primary_10_1038_s41531_025_00883_7
crossref_primary_10_1016_j_mam_2022_101096
crossref_primary_10_1177_1721727X221083763
crossref_primary_10_3233_JPD_181421
crossref_primary_10_1371_journal_pone_0258928
crossref_primary_10_1016_j_nbd_2023_106362
crossref_primary_10_1016_j_isci_2025_113162
crossref_primary_10_1002_mds_27823
crossref_primary_10_3390_molecules26133990
crossref_primary_10_1016_j_ecoenv_2020_111424
crossref_primary_10_1007_s40265_019_01104_1
crossref_primary_10_1093_brain_awaa019
crossref_primary_10_1038_s41531_018_0062_4
crossref_primary_10_7554_eLife_69795
crossref_primary_10_3389_fnagi_2025_1612913
crossref_primary_10_1038_s41467_022_34667_x
crossref_primary_10_1016_j_lfs_2023_122171
crossref_primary_10_1007_s12035_025_05153_4
crossref_primary_10_1038_s41420_024_02062_8
crossref_primary_10_3233_JND_200598
crossref_primary_10_1155_2020_1694547
crossref_primary_10_1016_j_dscb_2022_100031
crossref_primary_10_3390_ijms20215402
crossref_primary_10_1007_s00415_020_09892_3
crossref_primary_10_3389_fnagi_2023_1215495
crossref_primary_10_3389_fphar_2020_577017
crossref_primary_10_3390_brainsci8050084
crossref_primary_10_1002_nep3_59
crossref_primary_10_1038_s41531_021_00179_6
crossref_primary_10_1080_14737175_2019_1592677
crossref_primary_10_1080_00207454_2024_2377140
crossref_primary_10_3390_cells12232738
crossref_primary_10_1007_s00018_024_05383_0
crossref_primary_10_1186_s12883_021_02485_1
crossref_primary_10_3390_ijms22052737
crossref_primary_10_1016_j_neurobiolaging_2020_08_015
crossref_primary_10_1186_s40035_020_00200_7
crossref_primary_10_1007_s00429_023_02631_0
crossref_primary_10_3390_molecules26175327
crossref_primary_10_1016_j_phrs_2022_106375
crossref_primary_10_1186_s40035_020_00223_0
crossref_primary_10_1016_j_expneurol_2025_115242
crossref_primary_10_1016_j_nbd_2023_106105
crossref_primary_10_1016_j_nbd_2023_106226
crossref_primary_10_1016_j_expneurol_2024_115040
crossref_primary_10_1016_j_brainres_2024_149017
crossref_primary_10_20538_1682_0363_2022_4_105_113
crossref_primary_10_1007_s40266_018_0624_5
crossref_primary_10_1016_j_neuint_2023_105519
crossref_primary_10_1038_s41531_024_00799_8
crossref_primary_10_1371_journal_pcbi_1009371
crossref_primary_10_1093_brain_awab446
crossref_primary_10_1212_CON_0000000000000764
crossref_primary_10_1002_mds_27960
crossref_primary_10_1007_s00044_025_03409_1
crossref_primary_10_1523_ENEURO_0014_25_2025
crossref_primary_10_1212_WNL_0000000000200788
crossref_primary_10_25259_SNI_372_2021
crossref_primary_10_1016_j_mehy_2018_12_014
crossref_primary_10_1016_j_nbd_2019_104530
crossref_primary_10_1016_j_jbiomech_2019_05_039
crossref_primary_10_1093_brain_awz344
crossref_primary_10_1038_s41598_025_10082_2
crossref_primary_10_1096_fj_201802051R
crossref_primary_10_3389_fnagi_2023_1134472
crossref_primary_10_1016_j_pneurobio_2018_08_002
crossref_primary_10_1016_j_cger_2019_09_004
crossref_primary_10_1155_2022_6913691
crossref_primary_10_1007_s40473_018_0154_9
crossref_primary_10_1038_s41598_024_62786_6
crossref_primary_10_3389_fimmu_2024_1377409
crossref_primary_10_3390_pr11020319
crossref_primary_10_1016_j_phymed_2022_154044
crossref_primary_10_1152_jn_00548_2020
crossref_primary_10_1093_brain_awad325
crossref_primary_10_1002_mds_27743
crossref_primary_10_3389_fnagi_2020_00024
crossref_primary_10_3389_fnagi_2023_1117068
crossref_primary_10_3390_ijms23073678
crossref_primary_10_3233_JPD_213133
crossref_primary_10_7759_cureus_56144
crossref_primary_10_1016_j_clinph_2021_08_009
crossref_primary_10_1016_j_tins_2021_06_001
crossref_primary_10_1038_s41582_020_0344_4
crossref_primary_10_1016_j_biopha_2022_112924
crossref_primary_10_3389_fnagi_2021_763947
crossref_primary_10_3389_fnsyn_2021_636103
crossref_primary_10_2217_nmt_2019_0010
crossref_primary_10_1007_s00415_024_12770_x
crossref_primary_10_3390_healthcare9101263
crossref_primary_10_1016_j_sleep_2020_12_012
crossref_primary_10_1152_jn_00363_2021
crossref_primary_10_1007_s12152_019_09418_3
crossref_primary_10_3389_fneur_2018_00156
crossref_primary_10_3390_biomedicines13092191
crossref_primary_10_1111_jnc_14575
crossref_primary_10_3389_fphar_2022_914352
crossref_primary_10_2147_DDDT_S421449
crossref_primary_10_3389_fnagi_2020_00118
crossref_primary_10_1016_j_neulet_2025_138128
crossref_primary_10_1055_s_0043_1764291
crossref_primary_10_1016_j_wneu_2018_10_058
crossref_primary_10_1038_s41531_020_00125_y
crossref_primary_10_1016_j_parkreldis_2019_01_002
crossref_primary_10_1002_mds_28850
crossref_primary_10_3389_fnagi_2019_00134
crossref_primary_10_3390_ijms22126517
crossref_primary_10_1093_brain_awab001
crossref_primary_10_1007_s15202_017_1860_y
crossref_primary_10_1016_j_pharmthera_2024_108683
crossref_primary_10_1016_j_apsb_2025_07_012
crossref_primary_10_1016_j_cpet_2020_12_002
crossref_primary_10_1177_1877718X251315375
crossref_primary_10_1016_j_nbd_2024_106557
crossref_primary_10_1111_ejn_14699
crossref_primary_10_3389_fneur_2022_950715
crossref_primary_10_3390_brainsci12060698
crossref_primary_10_1146_annurev_neuro_112723_025516
crossref_primary_10_3389_fmolb_2021_676187
crossref_primary_10_1038_s41467_020_16046_6
crossref_primary_10_1088_1742_6596_1994_1_012006
crossref_primary_10_1155_2023_1262109
crossref_primary_10_3390_cells13151301
crossref_primary_10_3389_fnagi_2020_00230
crossref_primary_10_3389_fneur_2021_700600
crossref_primary_10_3389_fnhum_2022_809905
crossref_primary_10_3390_ijerph18052369
crossref_primary_10_1016_j_bioorg_2019_103459
crossref_primary_10_1007_s12035_024_04484_y
crossref_primary_10_3389_fnagi_2024_1308577
crossref_primary_10_3389_fnagi_2020_00232
crossref_primary_10_2147_CIA_S414714
crossref_primary_10_1016_j_clinph_2021_11_077
crossref_primary_10_1093_brain_awab073
crossref_primary_10_3389_fnana_2024_1362165
crossref_primary_10_1002_ana_25157
crossref_primary_10_1152_jn_00443_2020
crossref_primary_10_1093_cercor_bhab164
crossref_primary_10_3390_biom12121745
crossref_primary_10_1007_s00415_021_10873_3
crossref_primary_10_1007_s11064_018_2638_0
crossref_primary_10_1016_j_neuroscience_2019_04_058
crossref_primary_10_3233_JPD_202200
crossref_primary_10_1002_mds_29967
crossref_primary_10_1186_s40478_019_0713_7
crossref_primary_10_3233_JPD_171225
crossref_primary_10_1007_s00259_024_06822_7
crossref_primary_10_1007_s12035_020_02186_9
crossref_primary_10_1016_j_ejphar_2021_174262
crossref_primary_10_1186_s12974_024_03145_0
crossref_primary_10_1016_j_neures_2020_04_007
crossref_primary_10_1093_brain_awad123
crossref_primary_10_1016_j_fct_2023_114069
crossref_primary_10_2147_JIR_S333887
crossref_primary_10_1016_j_drugalcdep_2019_107595
crossref_primary_10_1186_s13578_021_00709_y
crossref_primary_10_1177_02692155231170690
crossref_primary_10_1002_btm2_10604
crossref_primary_10_1016_j_neulet_2022_136515
crossref_primary_10_1002_path_5777
crossref_primary_10_1080_14737175_2019_1656067
crossref_primary_10_1038_s41467_021_26519_x
crossref_primary_10_3389_fphar_2021_775087
crossref_primary_10_1038_s41598_023_38782_7
crossref_primary_10_3390_cells11182909
crossref_primary_10_1007_s40519_019_00648_1
crossref_primary_10_3389_fnagi_2024_1422535
crossref_primary_10_1002_mds_27534
crossref_primary_10_1093_brain_awad114
crossref_primary_10_1016_j_revmed_2020_06_019
crossref_primary_10_3390_ijerph19148799
crossref_primary_10_3390_ijms23116235
crossref_primary_10_1111_ene_15230
crossref_primary_10_4103_aian_aian_474_21
crossref_primary_10_1002_mds_29506
crossref_primary_10_1016_j_jocn_2019_08_082
crossref_primary_10_1038_s41531_021_00166_x
crossref_primary_10_1142_S0192415X21500282
crossref_primary_10_1155_2023_6755569
crossref_primary_10_3390_jcm14082716
crossref_primary_10_1038_s41467_019_12834_x
crossref_primary_10_1093_cercor_bhad252
crossref_primary_10_3389_fnagi_2019_00195
crossref_primary_10_1111_cbdd_14353
crossref_primary_10_1016_j_ccr_2023_215616
crossref_primary_10_1016_j_neuint_2024_105760
crossref_primary_10_1016_j_nrleng_2023_10_004
crossref_primary_10_3389_fnagi_2022_807909
crossref_primary_10_1111_ejn_16665
crossref_primary_10_1016_j_ajoc_2021_101124
crossref_primary_10_1111_ejn_16669
crossref_primary_10_3389_fnmol_2018_00343
crossref_primary_10_1111_jnc_15240
crossref_primary_10_1002_mds_27310
crossref_primary_10_1002_mds_27670
crossref_primary_10_1002_mds_27792
crossref_primary_10_1002_mds3_10154
crossref_primary_10_1016_j_ajp_2025_104537
crossref_primary_10_1093_brain_awab156
crossref_primary_10_3390_brainsci9090239
crossref_primary_10_3390_brainsci13030508
crossref_primary_10_1111_jnc_14969
crossref_primary_10_1007_s13311_020_00875_w
crossref_primary_10_3389_fnagi_2022_943438
crossref_primary_10_1007_s12640_022_00616_1
crossref_primary_10_1186_s13578_024_01328_z
crossref_primary_10_1016_j_cej_2023_142959
crossref_primary_10_1016_j_nicl_2023_103488
crossref_primary_10_1016_j_neuropharm_2021_108465
crossref_primary_10_1007_s00441_018_2856_4
crossref_primary_10_3390_ijms22147630
crossref_primary_10_1016_j_ceca_2024_102928
crossref_primary_10_1016_j_arr_2022_101560
crossref_primary_10_1002_mds_27347
crossref_primary_10_1016_j_jmb_2023_168023
crossref_primary_10_1038_s41531_023_00457_5
crossref_primary_10_1515_hsz_2019_0268
crossref_primary_10_1016_j_eswa_2024_125506
crossref_primary_10_1186_s12883_024_03887_7
crossref_primary_10_1016_j_parkreldis_2025_107807
crossref_primary_10_1515_revneuro_2020_0011
crossref_primary_10_3233_JPD_212684
crossref_primary_10_3390_biomedicines10092069
crossref_primary_10_1016_j_sajb_2020_06_028
crossref_primary_10_1186_s13024_020_00364_w
crossref_primary_10_1073_pnas_2204058119
crossref_primary_10_3389_fmed_2022_1073720
crossref_primary_10_3390_cells8020105
crossref_primary_10_1016_j_jnutbio_2022_108994
crossref_primary_10_1016_S1474_4422_18_30179_0
crossref_primary_10_1038_s41531_025_01108_7
crossref_primary_10_1002_mdc3_13523
crossref_primary_10_3390_metabo10110450
crossref_primary_10_1016_j_expneurol_2024_114704
crossref_primary_10_3390_ijms22105326
crossref_primary_10_3390_cells9092045
crossref_primary_10_1523_JNEUROSCI_0529_23_2023
crossref_primary_10_1111_pcn_13663
crossref_primary_10_1080_10715762_2018_1489128
crossref_primary_10_3389_fnins_2021_660942
crossref_primary_10_1007_s00259_021_05302_6
crossref_primary_10_1016_j_neuropharm_2023_109411
crossref_primary_10_1038_s41467_020_18689_x
crossref_primary_10_3390_molecules27238286
crossref_primary_10_1111_jnc_15834
crossref_primary_10_1126_scitranslmed_aay3069
crossref_primary_10_1016_j_expneurol_2024_114958
crossref_primary_10_2147_RMHP_S313212
crossref_primary_10_1016_j_nbd_2022_105668
crossref_primary_10_1002_med_22035
crossref_primary_10_1002_mds_27360
crossref_primary_10_3389_fgene_2022_856493
crossref_primary_10_1016_j_biomaterials_2025_123378
crossref_primary_10_1016_j_neurobiolaging_2020_11_005
crossref_primary_10_3390_pharmaceutics14050931
crossref_primary_10_3389_fncel_2022_1037903
crossref_primary_10_1016_j_parkreldis_2019_06_001
crossref_primary_10_3389_fpsyg_2025_1478500
crossref_primary_10_1016_j_jagp_2019_03_002
crossref_primary_10_1016_j_nicl_2023_103399
crossref_primary_10_1177_09636897221105499
crossref_primary_10_1002_mds_28685
crossref_primary_10_1002_mds_27113
crossref_primary_10_1590_1806_9282_65_6_791
crossref_primary_10_3390_biom14070756
crossref_primary_10_1016_j_neulet_2018_04_013
crossref_primary_10_1007_s00018_021_04047_7
crossref_primary_10_1016_j_dsp_2024_104407
crossref_primary_10_1002_mds_30202
crossref_primary_10_2217_epi_2023_0428
crossref_primary_10_1080_00207454_2020_1809394
crossref_primary_10_1016_j_bbr_2022_113733
crossref_primary_10_3390_biomedicines8120591
crossref_primary_10_3389_fneur_2023_1278065
crossref_primary_10_1155_padi_9739567
crossref_primary_10_1002_ana_25441
crossref_primary_10_1016_j_intimp_2024_112715
crossref_primary_10_3390_ijms24021685
crossref_primary_10_1016_j_parkreldis_2021_08_005
crossref_primary_10_1002_hbm_25223
crossref_primary_10_3389_fnsyn_2021_635050
crossref_primary_10_3390_ijms252413446
crossref_primary_10_1111_ejn_16136
crossref_primary_10_1016_j_jaut_2024_103256
crossref_primary_10_1002_adma_201806991
crossref_primary_10_1002_mds_29317
crossref_primary_10_1016_j_parkreldis_2022_01_011
crossref_primary_10_3390_cells11213445
crossref_primary_10_1109_TBME_2022_3172725
crossref_primary_10_1186_s13578_024_01313_6
crossref_primary_10_1136_jnnp_2019_322338
crossref_primary_10_1002_mds_28468
crossref_primary_10_3390_ijms232314997
crossref_primary_10_1016_j_phrs_2020_105279
crossref_primary_10_3390_ijms24076587
crossref_primary_10_1016_j_jchemneu_2023_102271
crossref_primary_10_1002_mds_29590
crossref_primary_10_3233_JPD_212671
crossref_primary_10_3390_cells9122580
crossref_primary_10_1111_jnc_14308
crossref_primary_10_1073_pnas_1906565116
crossref_primary_10_1001_jamaophthalmol_2020_1279
crossref_primary_10_31083_j_jin2306109
crossref_primary_10_1016_j_bbamem_2018_04_011
crossref_primary_10_3233_JPD_171285
crossref_primary_10_3390_ijms24065575
crossref_primary_10_1080_23279095_2021_2011727
crossref_primary_10_3390_biomedicines10092297
crossref_primary_10_3389_fneur_2025_1579556
crossref_primary_10_3390_ijms24087435
crossref_primary_10_4155_ppa_2020_0008
crossref_primary_10_1002_mdc3_12728
crossref_primary_10_3389_fnut_2022_809621
crossref_primary_10_1016_j_neulet_2019_134381
crossref_primary_10_3390_biomedicines10040760
crossref_primary_10_31083_j_jin2306114
crossref_primary_10_7554_eLife_90905
crossref_primary_10_1038_s41531_021_00206_6
crossref_primary_10_1212_WNL_0000000000007315
crossref_primary_10_1038_s41598_025_93737_4
crossref_primary_10_1093_brain_awae276
crossref_primary_10_3390_biomedicines10071486
crossref_primary_10_1007_s10072_023_07299_2
crossref_primary_10_1096_fj_202300133R
crossref_primary_10_3389_fnagi_2023_1257799
crossref_primary_10_1146_annurev_pharmtox_010818_021214
crossref_primary_10_1016_j_nbd_2018_09_016
crossref_primary_10_1111_cns_13149
crossref_primary_10_3389_fnmol_2019_00299
crossref_primary_10_1016_j_jns_2022_120196
crossref_primary_10_1038_s41598_022_07851_8
crossref_primary_10_1007_s10072_022_06050_7
crossref_primary_10_1016_j_arr_2021_101396
crossref_primary_10_1007_s12035_023_03206_0
crossref_primary_10_1016_j_engappai_2023_107494
crossref_primary_10_1109_TNSRE_2024_3435749
crossref_primary_10_3390_nu14020355
crossref_primary_10_1016_j_dscb_2025_100239
crossref_primary_10_1055_s_0043_1762913
crossref_primary_10_1212_WNL_0000000000206762
crossref_primary_10_3389_fnhum_2023_1248636
crossref_primary_10_3390_biom10091327
Cites_doi 10.1002/ana.20102
10.1016/j.jalz.2014.04.014
10.1016/j.neuron.2016.03.038
10.1007/s12311-016-0763-3
10.1002/mds.26481
10.1212/01.wnl.0000183056.89590.0d
10.1212/WNL.0000000000001020
10.1002/mds.26125
10.1002/mds.25037
10.1093/brain/aws093
10.1002/mds.26077
10.1002/mds.23664
10.1002/mds.21956
10.1093/brain/awv093
10.1056/NEJMoa033447
10.3171/jns.1958.15.3.0244
10.1002/mds.26796
10.1038/ng.3043
10.1002/mds.26615
10.1002/ana.22592
10.1212/WNL.0000000000002102
10.1002/mds.22908
10.1056/NEJM196702162760703
10.1212/WNL.0000000000001684
10.1016/j.neurobiolaging.2004.11.008
10.1038/nm1746
10.1007/s40263-016-0386-8
10.3389/fnagi.2014.00286
10.1111/j.1365-2990.2007.00923.x
10.1016/j.neuron.2004.10.023
10.1016/S1474-4422(13)70117-0
10.1136/jnnp.55.3.181
10.1002/ana.22361
10.1371/journal.pone.0089741
10.1093/brain/awp209
10.1093/brain/114.5.2283
10.1136/bmj.318.7179.311
10.1002/mds.26246
10.1002/ana.21461
10.1016/j.neuron.2013.01.020
10.1212/WNL.0000000000002350
10.1101/cshperspect.a024109
10.1093/brain/awv219
10.1002/mds.26192
10.1517/14656566.2016.1149163
10.1002/mds.26445
10.1126/science.287.5456.1265
10.1212/WNL.45.3.565
10.1002/mds.26119
10.1007/BF01562492
10.1002/ana.22282
10.1016/j.conb.2006.10.002
10.1016/S0306-4522(97)00295-9
10.1002/mds.25373
10.1093/brain/awt152
10.1002/mds.26935
10.1002/mds.26759
10.1038/35006074
10.1093/brain/aws281
10.1523/JNEUROSCI.23-10-04012.2003
10.1146/annurev-pharmtox-011613-135937
10.1212/01.wnl.0000242888.30755.5d
10.1093/brain/awv136
10.1212/WNL.0000000000002030
10.1002/mds.21751
10.1002/ana.22284
10.1016/j.ajhg.2011.06.001
10.1002/mds.26477
10.1002/ana.410270309
10.1002/mds.27099
10.1002/mds.23609
10.1212/01.wnl.0000336340.89821.b3
10.1002/mds.27002
10.1212/WNL.6.11.783
10.1212/01.wnl.0000191154.78131.f6
10.1093/brain/awv211
10.1016/j.neuron.2009.01.033
10.1002/mds.26354
10.1016/j.sleep.2012.10.009
10.1136/jnnp.51.6.745
10.1212/WNL.17.5.427
10.1016/j.parkreldis.2014.05.011
10.1212/01.wnl.0000286384.31050.b5
10.1172/JCI71640
10.1093/brain/awq212
10.1007/s00401-010-0664-3
10.1016/j.nicl.2013.10.006
10.1007/s40265-016-0566-3
10.1212/WNL.0b013e318294b3c8
10.1016/0166-2236(90)90109-N
10.1007/978-3-7091-6360-3_1
10.1002/ana.24436
10.3389/fnsys.2014.00005
10.1159/000449011
10.1093/brain/awt007
10.1016/j.cell.2015.08.014
10.1002/mds.25975
10.1002/mds.25217
10.1016/j.parkreldis.2005.12.008
10.1016/S1474-4422(11)70152-1
10.1126/science.1218632
10.1002/ana.20737
10.1002/mds.26370
10.1523/JNEUROSCI.5314-13.2014
10.1523/JNEUROSCI.20-22-08559.2000
10.1212/WNL.60.1.69
10.1523/JNEUROSCI.0234-12.2012
10.1001/archneur.64.7.990
10.1001/jamaneurol.2013.172
10.1002/mds.26714
10.3389/fnhum.2011.00179
10.1002/ana.24648
10.1002/mds.26424
10.1073/pnas.0605208103
10.1016/S1474-4422(09)70238-8
10.1038/nrneurol.2016.196
10.1093/brain/awh607
10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q
10.1212/WNL.0b013e318278fe32
10.1176/appi.ajp.2011.10111669
10.1002/mds.26209
10.1002/mds.26263
10.1002/mds.26527
10.1002/mds.26591
10.1016/j.tips.2009.12.006
10.1073/pnas.1300822110
10.1212/WNL.47.1.1
10.1097/01.WCB.0000126563.85360.75
10.1007/s00401-011-0852-9
10.1136/jnnp.52.Suppl.11
10.1136/jnnp-2014-309645
10.1212/WNL.0b013e31827deb74
10.1038/42166
10.1002/mds.25255
10.1002/mds.26432
10.1007/s11910-014-0501-5
10.1016/S0079-6123(03)43043-4
10.1212/WNL.0b013e31827f0fd1
10.1101/cshperspect.a009258
10.1212/WNL.0000000000000653
10.1038/nrn.2016.13
10.1093/brain/awt172
10.1001/archneurol.2010.65
10.1002/mds.26721
10.3171/jns.1959.16.1.0032
10.1038/1801200a0
10.1212/WNL.0b013e3182315259
10.1093/brain/awv215
10.1002/mds.26102
10.1093/hmg/ddv236
10.1093/brain/awq301
10.1212/WNL.0000000000002509
10.1016/j.neuron.2004.11.005
10.1212/WNL.0000000000000960
10.1002/mds.26662
10.3171/jns.1992.76.1.0053
10.1016/S0303-8467(03)00058-1
10.1016/j.ajhg.2011.06.008
10.1016/S0006-8993(97)01495-9
10.1002/mds.25076
10.1016/S1474-4422(08)70065-6
10.1002/ana.24664
10.1093/brain/awh445
10.1016/j.envint.2014.11.002
10.1016/j.neuroimage.2012.01.088
10.1038/jcbfm.1984.74
10.1136/jnnp-2013-305888
10.1111/j.1600-0447.1960.tb07606.x
10.1016/S0140-6736(13)62106-6
10.1016/S1474-4422(08)70117-0
10.1038/npp.2008.161
10.1016/S1474-4422(16)00080-6
10.1586/ern.12.47
10.1002/mds.26450
10.1212/WNL.0b013e31820f2d79
10.5962/bhl.title.131022
10.1002/ana.410420508
10.1089/jcr.2014.0028
10.1212/WNL.0b013e3181feb2ab
10.1212/01.wnl.0000324625.00404.15
10.1016/j.neurobiolaging.2012.07.018
10.1371/journal.pone.0012122
10.1002/mds.870050213
10.1016/S1474-4422(13)70047-4
10.1212/WNL.0000000000000592
10.1002/ana.20915
10.1093/brain/awm142
10.1002/mds.24051
10.1016/j.tins.2007.03.009
10.1002/mds.26510
10.1126/science.3059497
10.1002/mds.25344
10.3389/fnins.2016.00012
10.1016/j.parkreldis.2015.12.008
10.1002/mds.26521
10.1093/brain/awh676
10.1002/mds.23468
10.1074/jbc.R112.410530
10.1093/brain/awu020
10.1001/archneur.1969.00480160015001
10.1002/mds.26966
10.1002/mds.26201
10.1056/NEJM198911163212004
10.1002/mds.26657
10.1016/S0197-4580(02)00065-9
10.1002/mds.26599
10.1002/mds.10140
10.1002/mds.23795
10.1002/mds.26723
10.1002/mds.870120638
10.1002/mds.25844
10.1126/science.1227157
10.1002/mds.26421
10.1126/science.140.3565.394
10.1016/j.biopsych.2015.08.013
10.1212/WNL.0b013e31821ccce4
10.1212/01.wnl.0000326146.60732.d6
10.1093/brain/awh290
10.1001/jamaneurol.2013.5528
10.1002/mds.26054
10.1371/journal.pone.0133863
10.1016/S0072-9752(07)83005-3
10.1093/brain/awt360
10.1002/mds.26018
10.1016/0014-2999(68)90164-7
10.1016/j.tins.2016.09.003
10.1002/mds.24985
10.1016/j.neuron.2011.08.033
10.1056/NEJMoa041470
10.1001/archneurol.2009.294
10.1002/ana.410390107
10.1016/S1474-4422(13)70048-6
10.1212/01.wnl.0000306697.48738.b6
10.1073/pnas.0908005106
10.1016/j.tins.2009.06.003
10.1016/0140-6736(92)90457-E
10.1038/nrn.2016.178
10.1002/ana.24066
10.1016/S1474-4422(15)00227-6
10.1002/mds.26431
10.1136/jnnp.2007.127878
10.1016/j.pneurobio.2015.09.012
10.1212/WNL.0b013e3182516244
10.1002/mds.26815
10.1073/pnas.0903691106
10.1016/j.neuroimage.2010.09.028
10.1056/NEJMoa1600159
10.2967/jnumed.111.089946
10.1016/0166-2236(90)90110-V
10.1056/NEJMoa0809335
10.1126/science.290.5492.767
10.1126/science.276.5321.2045
10.1002/mds.25020
10.1002/ana.24385
10.1371/journal.pone.0070244
10.1080/15216540152845939
10.1002/mds.26332
10.1016/j.expneurol.2015.02.020
10.1017/S0317167100010209
10.1016/j.neuron.2011.06.003
10.1002/mds.26636
10.1007/s00415-012-6745-6
10.1002/ana.23614
10.1002/ana.410340304
10.1038/23281
10.1038/nm1747
10.1212/WNL.56.6.730
10.1093/brain/awu193
10.1016/S0140-6736(14)61010-2
10.1126/science.6823561
10.1002/mds.24893
10.1002/mds.26562
10.1001/jamaneurol.2015.0703
10.1212/WNL.0b013e3181f11c1d
10.1002/mds.870070204
10.1002/mds.22839
10.1002/mds.26890
10.1126/science.1090278
10.1002/mds.870131303
10.1016/j.expneurol.2014.03.011
10.1002/ana.24098
ContentType Journal Article
Copyright 2017 International Parkinson and Movement Disorder Society
2017 International Parkinson and Movement Disorder Society.
Copyright_xml – notice: 2017 International Parkinson and Movement Disorder Society
– notice: 2017 International Parkinson and Movement Disorder Society.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
5PM
DOI 10.1002/mds.27115
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Genetics Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Nursing & Allied Health Premium
MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1531-8257
EndPage 1310
ExternalDocumentID PMC5685546
28887905
10_1002_mds_27115
MDS27115
Genre reviewArticle
Historical Article
Journal Article
Review
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: P50 NS053488
– fundername: NINDS NIH HHS
  grantid: R01 NS034696
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1CY
1L6
1OB
1OC
1ZS
31~
33P
3PY
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWD
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
YCJ
ZGI
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c5095-daeb8da38a30864662dcfd79a493c67f099f2d541f5c0c1f4bb1ec3b30feaf7f3
IEDL.DBID DRFUL
ISICitedReferencesCount 392
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000412293000059&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0885-3185
1531-8257
IngestDate Tue Nov 04 01:55:55 EST 2025
Sun Nov 09 10:16:31 EST 2025
Sat Nov 29 14:31:54 EST 2025
Mon Jul 21 06:05:43 EDT 2025
Sat Nov 29 07:08:34 EST 2025
Tue Nov 18 21:57:37 EST 2025
Wed Jan 22 16:30:00 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Shaking Palsy
Parkinson's disease
200 years anniversary
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2017 International Parkinson and Movement Disorder Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5095-daeb8da38a30864662dcfd79a493c67f099f2d541f5c0c1f4bb1ec3b30feaf7f3
Notes This article was published online on 11 September 2017. After online publication, an update was made to the text. This notice is included in the online and print versions to indicate that both have been corrected on 15 September 2017.
Nothing to report.
Relevant conflicts of interests/financial disclosures
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-4176-9196
0000-0003-0422-8398
0000-0003-2921-8348
0000-0003-1367-6467
0000-0002-6041-9941
0000-0003-1668-9925
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/5685546
PMID 28887905
PQID 1936787246
PQPubID 1016421
PageCount 48
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5685546
proquest_miscellaneous_1937531778
proquest_journals_1936787246
pubmed_primary_28887905
crossref_primary_10_1002_mds_27115
crossref_citationtrail_10_1002_mds_27115
wiley_primary_10_1002_mds_27115_MDS27115
PublicationCentury 2000
PublicationDate September 2017
2017-09-00
2017-Sep
20170901
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: September 2017
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Movement disorders
PublicationTitleAlternate Mov Disord
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 1960; 35
1968; 5
2004; 24
2016; 32
1999; 46
2016; 31
2016; 30
2008; 34
2013; 70
2005; 65
1967; 276
2017; 155
2016; 39
1992; 55
2012; 12
1992; 7
2015; 138
2000; 404
1967; 17
1999; 56
2008; 23
2012; 28
2012; 27
2013; 110
2001; 56
1824; 1
2010; 5
2011; 122
2001; 52
2004; 44
2009; 62
2009; 64
2016; 10
2016; 17
2016; 16
2016; 15
2012; 32
2004; 55
1963; 140
2013; 77
1995; 45
2013; 80
1956; 6
1807
1805
1804
2016; 23
1996; 39
1990; 13
2013; 28
2008; 7
2008; 79
2007; 30
2008; 72
1817
2008; 70
2008; 71
2000; 290
2010; 67
2013; 14
1953; 27
2013; 12
2017; 32
2007; 130
2000; 287
2014; 9
2014; 8
2012; 336
2014; 6
2012; 338
2014; 54
2015; 162
2010; 75
2015; 5
2006; 12
2006; 16
1833
2014; 85
1992; 76
2014; 83
1993; 149
2007; 59
2013; 34
2017; 13
2010; 134
2015; 274
2010; 133
2016; 375
2017
2009; 8
2017; 18
1996; 47
2003; 302
2003; 60
2014; 71
2014; 75
2007; 104
2002; 17
2015; 78
2013; 3
1991; 114
1997; 42
2015; 72
2015; 75
1997; 276
2015; 77
2011; 52
2011; 54
2014; 29
1998; 83
2013; 8
2014; 137
2014; 20
2014; 256
1997; 388
1993; 34
2010; 25
2012; 135
2010; 119
2015; 84
2015; 85
2011; 70
2011; 72
2014; 14
2009; 361
2011; 69
2007; 64
2003; 44
2014; 10
2014; 124
2004; 143
2010; 31
2010; 37
1877
2011; 77
2011; 76
2014; 46
2016; 94
1989; 52
2003; 105
1984; 4
1990; 27
1969; 21
2005; 128
2003; 24
1998; 789
1886
2007; 83
2011; 89
2014; 30
2014; 383
2014; 384
2014; 34
1990; 5
2003; 23
2009; 106
2012; 60
2004; 127
2012; 288
1958; 15
1817; 8
1987; 4
2015; 31
2015; 30
2016; 76
2011; 10
1999; 400
2005; 26
1789; 2
2016; 79
2012; 72
2012; 71
2006; 60
2011; 168
2016; 90
2006; 67
1997; 12
2016; 87
2016; 86
2011; 26
2011; 27
2015; 14
1992; 340
2000; 20
2015; 10
2009; 132
2008; 14
2008; 13
1988; 242
1988; 51
2012; 79
2013; 260
2012; 78
1983; 219
2015; 24
2009; 34
2004; 351
2012; 2
2009; 32
1989; 321
1988; 7
1940; 44
2013; 136
1957; 180
1959; 16
2012; 5
1999; 318
e_1_2_8_241_1
e_1_2_8_287_1
Kim SE (e_1_2_8_129_1) 2003; 44
e_1_2_8_264_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_203_1
e_1_2_8_249_1
Kosaka K (e_1_2_8_74_1) 1988; 7
e_1_2_8_226_1
e_1_2_8_132_1
e_1_2_8_155_1
e_1_2_8_178_1
e_1_2_8_9_1
e_1_2_8_117_1
e_1_2_8_170_1
e_1_2_8_193_1
e_1_2_8_290_1
e_1_2_8_64_1
e_1_2_8_87_1
e_1_2_8_41_1
e_1_2_8_230_1
e_1_2_8_276_1
e_1_2_8_253_1
e_1_2_8_38_1
e_1_2_8_291_1
e_1_2_8_238_1
e_1_2_8_215_1
e_1_2_8_120_1
e_1_2_8_143_1
e_1_2_8_166_1
e_1_2_8_189_1
e_1_2_8_91_1
e_1_2_8_99_1
e_1_2_8_105_1
e_1_2_8_128_1
e_1_2_8_181_1
e_1_2_8_53_1
e_1_2_8_76_1
e_1_2_8_30_1
e_1_2_8_242_1
e_1_2_8_265_1
e_1_2_8_25_1
e_1_2_8_280_1
e_1_2_8_48_1
e_1_2_8_227_1
e_1_2_8_288_1
e_1_2_8_204_1
e_1_2_8_2_1
e_1_2_8_133_1
e_1_2_8_179_1
e_1_2_8_110_1
e_1_2_8_171_1
e_1_2_8_86_1
e_1_2_8_118_1
e_1_2_8_194_1
e_1_2_8_63_1
e_1_2_8_40_1
e_1_2_8_156_1
Parkinson J (e_1_2_8_3_1) 1833
e_1_2_8_231_1
e_1_2_8_254_1
e_1_2_8_292_1
e_1_2_8_37_1
e_1_2_8_239_1
e_1_2_8_216_1
e_1_2_8_277_1
e_1_2_8_144_1
e_1_2_8_90_1
e_1_2_8_121_1
e_1_2_8_98_1
e_1_2_8_106_1
e_1_2_8_75_1
e_1_2_8_52_1
e_1_2_8_167_1
Parkinson J (e_1_2_8_5_1) 1807
e_1_2_8_28_1
e_1_2_8_243_1
e_1_2_8_220_1
e_1_2_8_281_1
Parkinson J (e_1_2_8_8_1) 1824; 1
e_1_2_8_228_1
e_1_2_8_266_1
e_1_2_8_205_1
e_1_2_8_289_1
e_1_2_8_81_1
e_1_2_8_111_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_66_1
e_1_2_8_89_1
e_1_2_8_119_1
e_1_2_8_172_1
e_1_2_8_195_1
Gowers WR (e_1_2_8_22_1) 1886
e_1_2_8_134_1
e_1_2_8_157_1
e_1_2_8_17_1
e_1_2_8_232_1
e_1_2_8_293_1
e_1_2_8_270_1
e_1_2_8_217_1
e_1_2_8_255_1
e_1_2_8_278_1
e_1_2_8_70_1
Pollak P (e_1_2_8_188_1) 1993; 149
e_1_2_8_122_1
e_1_2_8_160_1
e_1_2_8_32_1
e_1_2_8_55_1
e_1_2_8_78_1
e_1_2_8_107_1
e_1_2_8_183_1
e_1_2_8_145_1
e_1_2_8_168_1
e_1_2_8_93_1
e_1_2_8_221_1
e_1_2_8_282_1
e_1_2_8_27_1
e_1_2_8_229_1
e_1_2_8_244_1
e_1_2_8_267_1
e_1_2_8_206_1
e_1_2_8_80_1
e_1_2_8_150_1
e_1_2_8_42_1
e_1_2_8_88_1
e_1_2_8_65_1
e_1_2_8_173_1
e_1_2_8_112_1
e_1_2_8_158_1
e_1_2_8_196_1
e_1_2_8_135_1
e_1_2_8_39_1
e_1_2_8_210_1
e_1_2_8_271_1
e_1_2_8_294_1
e_1_2_8_16_1
e_1_2_8_218_1
e_1_2_8_233_1
e_1_2_8_256_1
e_1_2_8_279_1
e_1_2_8_92_1
e_1_2_8_100_1
e_1_2_8_161_1
e_1_2_8_31_1
e_1_2_8_77_1
e_1_2_8_54_1
e_1_2_8_108_1
e_1_2_8_184_1
e_1_2_8_123_1
e_1_2_8_169_1
e_1_2_8_146_1
e_1_2_8_283_1
e_1_2_8_68_1
e_1_2_8_260_1
e_1_2_8_222_1
e_1_2_8_207_1
e_1_2_8_245_1
e_1_2_8_268_1
e_1_2_8_151_1
e_1_2_8_45_1
e_1_2_8_113_1
e_1_2_8_136_1
e_1_2_8_159_1
e_1_2_8_174_1
e_1_2_8_197_1
e_1_2_8_60_1
e_1_2_8_83_1
Myers RH (e_1_2_8_182_1) 1940; 44
e_1_2_8_19_1
e_1_2_8_295_1
e_1_2_8_109_1
e_1_2_8_272_1
e_1_2_8_57_1
e_1_2_8_234_1
e_1_2_8_257_1
e_1_2_8_95_1
e_1_2_8_219_1
e_1_2_8_162_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_101_1
e_1_2_8_124_1
e_1_2_8_147_1
e_1_2_8_185_1
e_1_2_8_72_1
Parkinson J (e_1_2_8_7_1) 1805
Parkinson J (e_1_2_8_4_1) 1804
e_1_2_8_29_1
e_1_2_8_284_1
Parkinson J (e_1_2_8_6_1) 1789; 2
e_1_2_8_261_1
e_1_2_8_200_1
e_1_2_8_223_1
e_1_2_8_246_1
e_1_2_8_269_1
e_1_2_8_152_1
e_1_2_8_208_1
e_1_2_8_21_1
e_1_2_8_67_1
e_1_2_8_44_1
e_1_2_8_137_1
e_1_2_8_175_1
e_1_2_8_82_1
e_1_2_8_114_1
e_1_2_8_198_1
e_1_2_8_18_1
e_1_2_8_273_1
e_1_2_8_296_1
e_1_2_8_250_1
e_1_2_8_79_1
e_1_2_8_212_1
e_1_2_8_235_1
e_1_2_8_258_1
e_1_2_8_94_1
e_1_2_8_163_1
Burrows G (e_1_2_8_12_1) 1817; 8
e_1_2_8_140_1
e_1_2_8_56_1
e_1_2_8_33_1
e_1_2_8_102_1
e_1_2_8_148_1
e_1_2_8_186_1
e_1_2_8_71_1
e_1_2_8_125_1
Parkinson J (e_1_2_8_10_1) 1817
e_1_2_8_262_1
e_1_2_8_285_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_224_1
e_1_2_8_201_1
e_1_2_8_247_1
e_1_2_8_130_1
e_1_2_8_153_1
e_1_2_8_209_1
Piconi B (e_1_2_8_138_1) 2017; 32
e_1_2_8_62_1
e_1_2_8_85_1
e_1_2_8_115_1
e_1_2_8_176_1
e_1_2_8_199_1
e_1_2_8_251_1
e_1_2_8_297_1
e_1_2_8_274_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_59_1
e_1_2_8_190_1
e_1_2_8_213_1
e_1_2_8_259_1
e_1_2_8_236_1
e_1_2_8_141_1
e_1_2_8_164_1
e_1_2_8_97_1
e_1_2_8_149_1
e_1_2_8_51_1
Fahn S (e_1_2_8_14_1) 1987; 4
e_1_2_8_103_1
e_1_2_8_126_1
e_1_2_8_187_1
e_1_2_8_240_1
e_1_2_8_263_1
e_1_2_8_286_1
e_1_2_8_46_1
e_1_2_8_69_1
e_1_2_8_180_1
e_1_2_8_202_1
e_1_2_8_225_1
e_1_2_8_248_1
e_1_2_8_154_1
e_1_2_8_131_1
e_1_2_8_192_1
e_1_2_8_300_1
e_1_2_8_116_1
e_1_2_8_23_1
e_1_2_8_139_1
e_1_2_8_84_1
e_1_2_8_61_1
e_1_2_8_177_1
e_1_2_8_252_1
e_1_2_8_275_1
e_1_2_8_298_1
Bar‐Gad I (e_1_2_8_211_1) 2003; 23
e_1_2_8_35_1
e_1_2_8_58_1
e_1_2_8_191_1
Charcot JM (e_1_2_8_15_1) 1877
e_1_2_8_214_1
e_1_2_8_237_1
e_1_2_8_165_1
e_1_2_8_96_1
e_1_2_8_142_1
Chaudhuri KR (e_1_2_8_299_1) 2017; 32
e_1_2_8_127_1
e_1_2_8_73_1
e_1_2_8_50_1
e_1_2_8_104_1
References_xml – volume: 12
  start-page: 673
  year: 2012
  end-page: 686
  article-title: Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?
  publication-title: Expert Rev Neurother
– volume: 8
  start-page: 1150
  issue: 12
  year: 2009
  end-page: 1157
  article-title: Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
  publication-title: Lancet Neurol
– year: 1805
– volume: 106
  start-page: 13010
  issue: 31
  year: 2009
  end-page: 13015
  article-title: Inclusion formation and neuronal cell death through neuron‐to‐neuron transmission of alpha‐synuclein
  publication-title: Proc Natl Acad Sci U S A
– volume: 60
  start-page: 366
  issue: 3
  year: 2006
  end-page: 373
  article-title: NOS2A and the modulating effect of cigarette smoking in Parkinson's disease
  publication-title: Ann Neurol
– volume: 32
  start-page: 548
  issue: 10
  year: 2009
  end-page: 557
  article-title: Metabolic brain networks in neurodegenerative disorders: a functional imaging approach
  publication-title: Trends Neurosci
– volume: 180
  start-page: 1200
  issue: 4596
  year: 1957
  article-title: 3,4‐Dihydroxyphenylalanine and 5‐hydroxytryptophan as reserpine antagonists
  publication-title: Nature
– volume: 60
  start-page: 69
  issue: 1
  year: 2003
  end-page: 73
  article-title: Randomized, double‐blind trial of glial cell line‐derived neurotrophic factor (GDNF) in PD
  publication-title: Neurology
– volume: 29
  start-page: 1758
  issue: 14
  year: 2014
  end-page: 1766
  article-title: The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases
  publication-title: Mov Disord
– volume: 10
  start-page: e0133863
  issue: 7
  year: 2015
  article-title: Did α‐synuclein and glucocerebrosidase coevolve? Implications for Parkinson's disease
  publication-title: PLoS ONE
– volume: 84
  start-page: 2422
  issue: 24
  year: 2015
  end-page: 2429
  article-title: Depression and subsequent risk of Parkinson disease: a nationwide cohort study
  publication-title: Neurology
– volume: 31
  start-page: 1619
  issue: 11
  year: 2016
  end-page: 1622
  article-title: Arguing against the proposed definition changes of PD
  publication-title: Mov Disord
– volume: 80
  start-page: 496
  issue: 5
  year: 2013
  end-page: 503
  article-title: Criteria for the diagnosis of corticobasal degeneration
  publication-title: Neurology
– volume: 135
  start-page: 1860
  issue: 6
  year: 2012
  end-page: 1870
  article-title: How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder
  publication-title: Brain
– volume: 31
  start-page: 178
  issue: 2
  year: 2016
  end-page: 192
  article-title: Autophagy and alpha‐synuclein: relevance to Parkinson's disease and related synucleopathies
  publication-title: Mov Disord
– volume: 28
  start-page: 31
  year: 2013
  end-page: 40
  article-title: Parkinson's disease and alpha synuclein: is Parkinson's disease a prion‐like disorder?
  publication-title: Mov Disord
– volume: 13
  start-page: 119
  issue: 2
  year: 2017
  end-page: 126
  article-title: Precision medicine for disease modification in Parkinson disease
  publication-title: Nat Rev Neurol
– volume: 31
  start-page: 1226
  issue: 8
  year: 2016
  end-page: 1230
  article-title: Motor and nonmotor features of carriers of the p.A53T alpha‐synuclein mutation: a longitudinal study
  publication-title: Mov Disord
– volume: 12
  start-page: 514
  issue: 5
  year: 2013
  end-page: 524
  article-title: Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
  publication-title: Lancet Neurol
– volume: 52
  start-page: 135
  issue: 3‐5
  year: 2001
  end-page: 141
  article-title: Complex I and Parkinson's disease
  publication-title: IUBMB Life
– volume: 105
  start-page: 262
  issue: 4
  year: 2003
  end-page: 269
  article-title: [18F]fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease
  publication-title: Clin Neurol Neurosurg
– volume: 35
  start-page: 358
  issue: 3
  year: 1960
  end-page: 377
  article-title: Treatment of parkinsonism by stereotactic thermolesions in the pallidal region. A clinical evaluation of 81 cases
  publication-title: Acta Psychiatrica Scandinavica
– volume: 71
  start-page: 267
  issue: 2
  year: 2012
  end-page: 277
  article-title: Seven‐tesla magnetic resonance images of the substantia nigra in Parkinson disease
  publication-title: Ann Neurol
– volume: 10
  start-page: S213
  issue: 3
  year: 2014
  end-page: S225
  article-title: The disease intersection of susceptibility and exposure: Chemical exposures and neurodegenerative disease risk
  publication-title: Alzheimers Dement
– volume: 132
  start-page: 2970
  issue: 11
  year: 2009
  end-page: 2979
  article-title: Longitudinal progression of sporadic Parkinson's disease: a multi‐tracer positron emission tomography study
  publication-title: Brain
– volume: 31
  start-page: 791
  issue: 6
  year: 2016
  end-page: 801
  article-title: Lysosomal dysfunction and α‐synuclein aggregation in Parkinson's disease: diagnostic links
  publication-title: Mov Disord
– volume: 30
  start-page: 1600
  issue: 12
  year: 2015
  end-page: 1611
  article-title: MDS research criteria for prodromal Parkinson's disease
  publication-title: Mov Disord
– volume: 21
  start-page: 343
  issue: 4
  year: 1969
  end-page: 354
  article-title: Treatment of parkinsonism with levodopa
  publication-title: Arch Neurol
– volume: 25
  start-page: 763
  issue: 6
  year: 2010
  end-page: 766
  article-title: The changing face of Parkinson's disease‐associated psychosis: a cross‐sectional study based on the new NINDS‐NIMH criteria
  publication-title: Mov Disord
– start-page: a024109
  year: 2017
  article-title: Genetics of synucleinopathies
  publication-title: Cold Spring Harb Perspect Med
– volume: 26
  start-page: 1343
  issue: 10
  year: 2005
  end-page: 1355
  article-title: Somatic mitochondrial DNA mutations in single neurons and glia
  publication-title: Neurobiol Aging
– volume: 137
  start-page: 2493
  issue: 9
  year: 2014
  end-page: 2508
  article-title: Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease
  publication-title: Brain
– volume: 26
  start-page: 416
  year: 2011
  end-page: 423
  article-title: Akinetic‐rigid and tremor‐dominant Parkinson's disease patients show different patterns of FP‐CIT single photon emission computed tomography
  publication-title: Mov Disord
– volume: 83
  start-page: 107
  issue: 1
  year: 1998
  end-page: 121
  article-title: Patterns of bursting occurring in thalamic cells during parkinsonian tremor
  publication-title: Neuroscience
– volume: 14
  start-page: 501
  issue: 5
  year: 2008
  end-page: 503
  article-title: Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host‐to‐graft disease propagation
  publication-title: Nat Med
– volume: 13
  start-page: 281
  issue: 7
  year: 1990
  end-page: 285
  article-title: Primate models of movement disorders of basal ganglia origin
  publication-title: Trends Neurosci
– volume: 30
  start-page: 229
  issue: 2
  year: 2015
  end-page: 237
  article-title: The onset of nonmotor symptoms in Parkinson's disease (the ONSET PDStudy)
  publication-title: Mov Disord
– volume: 32
  year: 2017
  article-title: Motor complications in Parkinson's disease: molecular and electrophysiological mechanisms of dyskinesias
  publication-title: Mov Disord
– volume: 27
  start-page: 54
  issue: 1
  year: 2012
  end-page: 60
  article-title: Toward a redefinition of Parkinson's disease
  publication-title: Mov Disord
– volume: 23
  start-page: 4012
  issue: 10
  year: 2003
  end-page: 4016
  article-title: Functional correlations between neighboring neurons in the primate globus pallidus are weak or nonexistent
  publication-title: J Neurosci
– volume: 321
  start-page: 1364
  issue: 20
  year: 1989
  end-page: 1371
  article-title: Effect of deprenyl on the progression of disability in early Parkinson's disease
  publication-title: N Engl J Med
– volume: 18
  start-page: 101
  issue: 2
  year: 2017
  end-page: 113
  article-title: Selective neuronal vulnerability in Parkinson disease
  publication-title: Nat Rev Neurosci
– volume: 89
  start-page: 168
  issue: 1
  year: 2011
  end-page: 175
  article-title: A mutation in VPS35, encoding a subunit of the retromer complex, causes late‐onset Parkinson disease
  publication-title: Am J Hum Genet
– volume: 34
  start-page: 324
  issue: 3
  year: 1993
  end-page: 330
  article-title: Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels
  publication-title: Ann Neurol
– volume: 14
  start-page: 744
  issue: 8
  year: 2013
  end-page: 748
  article-title: Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16‐year update on a previously reported series
  publication-title: Sleep Med
– volume: 134
  start-page: 36
  issue: 1
  year: 2010
  end-page: 49
  article-title: Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease
  publication-title: Brain
– volume: 23
  start-page: 1
  year: 2016
  end-page: 9
  article-title: Environmental risk factors and Parkinson's disease: an umbrella review of meta‐analyses
  publication-title: Parkinsonism Relat Disord
– volume: 75
  start-page: 144
  year: 2015
  end-page: 150
  article-title: Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease
  publication-title: Environ Int
– volume: 30
  start-page: 850
  issue: 6
  year: 2015
  end-page: 854
  article-title: Genetic risk and age in Parkinson's disease: continuum not stratum
  publication-title: Mov Disord
– volume: 31
  start-page: 906
  issue: 6
  year: 2016
  end-page: 914
  article-title: Cerebrospinal fluid biomarkers and clinical features in leucine‐rich repeat kinase 2 (LRRK2) mutation carriers
  publication-title: Mov Disord
– volume: 17
  start-page: S28
  issue: S3
  year: 2002
  end-page: S40
  article-title: Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back
  publication-title: Mov Disord
– volume: 23
  start-page: 837
  issue: 6
  year: 2008
  end-page: 844
  article-title: The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years
  publication-title: Mov Disord
– volume: 67
  start-page: 589
  year: 2010
  end-page: 595
  article-title: Impulse control disorders in Parkinson disease: a cross‐sectional study of 3090 patients
  publication-title: Arch Neurol
– volume: 75
  start-page: 331
  issue: 3
  year: 2014
  end-page: 333
  article-title: Do prions cause Parkinson disease? The evidence accumulates
  publication-title: Ann Neurol
– volume: 138
  start-page: 1667
  issue: 6
  year: 2015
  end-page: 1678
  article-title: The relative phases of basal ganglia activities dynamically shape effective connectivity in Parkinson's disease
  publication-title: Brain
– volume: 143
  start-page: 461
  year: 2004
  end-page: 466
  article-title: A new dynamic model of the cortico‐basal ganglia loop
  publication-title: Prog Brain Res
– volume: 75
  start-page: 351
  issue: 3
  year: 2014
  end-page: 362
  article-title: Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys
  publication-title: Ann Neurol
– volume: 76
  start-page: 863
  issue: 10
  year: 2011
  end-page: 869
  article-title: Use of ibuprofen and risk of Parkinson disease
  publication-title: Neurology
– volume: 288
  start-page: 10736
  issue: 15
  year: 2012
  end-page: 10741
  article-title: Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease
  publication-title: J Biol Chem
– volume: 274
  start-page: 42
  year: 2015
  end-page: 51
  article-title: Flies with Parkinson's disease
  publication-title: Exp Neurol
– volume: 13
  start-page: 277
  issue: 7
  year: 1990
  end-page: 280
  article-title: Disinhibition as a basic process in the expression of striatal functions
  publication-title: Trends Neurosci
– volume: 15
  start-page: 244
  issue: 3
  year: 1958
  end-page: 250
  article-title: Chemopallidectomy and chemothalamectomy
  publication-title: J Neurosurg
– volume: 10
  start-page: 797
  issue: 9
  year: 2011
  end-page: 805
  article-title: Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid‐eye‐movement sleep behaviour disorder: a prospective study
  publication-title: Lancet Neurol
– volume: 336
  start-page: 1306
  issue: 6086
  year: 2012
  end-page: 1310
  article-title: Vitamin K2 is a mitochondrial electron carrier that rescues Pink1 deficiency
  publication-title: Science
– volume: 128
  start-page: 2777
  issue: 12
  year: 2005
  end-page: 2785
  article-title: PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
  publication-title: Brain
– volume: 54
  start-page: 1244
  issue: 2
  year: 2011
  end-page: 1253
  article-title: Parkinson's disease tremor‐related metabolic network: Characterization, progression, and treatment effects
  publication-title: NeuroImage
– volume: 64
  start-page: 990
  issue: 7
  year: 2007
  end-page: 997
  article-title: Pooled analysis of tobacco use and risk of Parkinson disease
  publication-title: Arch Neurol
– volume: 70
  start-page: 1042
  issue: 13
  year: 2008
  end-page: 1048
  article-title: Patterns and stages of alpha‐synucleinopathy: relevance in a population‐based cohort
  publication-title: Neurology
– volume: 5
  start-page: e12122
  issue: 8
  year: 2010
  article-title: α‐synuclein suppression by targeted small interfering RNA in the primate substantia nigra
  publication-title: PLoS ONE
– volume: 56
  start-page: 730
  issue: 6
  year: 2001
  end-page: 736
  article-title: Risk of dementia in Parkinson's disease: a community‐based, prospective study
  publication-title: Neurology
– volume: 32
  start-page: 11750
  issue: 34
  year: 2012
  end-page: 11762
  article-title: Extracellular alpha‐synuclein oligomers modulate synaptic transmission and impair LTP via NMDA‐receptor activation
  publication-title: J Neurosci
– volume: 137
  start-page: 1481
  issue: 5
  year: 2014
  end-page: 1495
  article-title: Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation‐linked Parkinson disease cells
  publication-title: Brain
– volume: 94
  start-page: 307
  issue: 5
  year: 2016
  end-page: 319
  article-title: Pedunculopontine nucleus region deep brain stimulation in Parkinson disease: surgical techniques, side effects, and postoperative imaging
  publication-title: Stereotact Funct Neurosurg
– volume: 168
  start-page: 1066
  issue: 10
  year: 2011
  end-page: 1074
  article-title: Cognitive‐behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial
  publication-title: Am J Psychiatry
– volume: 136
  start-page: 2405
  issue: 8
  year: 2013
  end-page: 2418
  article-title: Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait
  publication-title: Brain
– volume: 71
  start-page: 903
  issue: 12
  year: 2008
  end-page: 910
  article-title: Imaging amyloid deposition in Lewy body diseases
  publication-title: Neurology
– volume: 54
  start-page: 141
  issue: 1
  year: 2014
  end-page: 164
  article-title: Environmental toxins and Parkinson's disease
  publication-title: Annu Rev Pharmacol Toxicol
– volume: 351
  start-page: 2509
  issue: 24
  year: 2004
  end-page: 2518
  article-title: Rivastigmine for dementia associated with Parkinson's disease
  publication-title: N Engl J Med
– year: 1817
– volume: 27
  start-page: 1659
  issue: 13
  year: 2012
  end-page: 1665
  article-title: Polychlorinated biphenyls in prospectively collected serum and Parkinson's disease risk
  publication-title: Mov Disord
– volume: 30
  start-page: 37
  issue: 1
  year: 2014
  end-page: 44
  article-title: Levodopa: effect on cell death and the natural history of Parkinson's disease
  publication-title: Mov Disord
– volume: 67
  start-page: 1612
  issue: 9
  year: 2006
  end-page: 1617
  article-title: Clinical correlates of levodopa‐induced dopamine release in Parkinson disease: a PET study
  publication-title: Neurology
– volume: 32
  start-page: 5
  issue: 1
  year: 2016
  end-page: 10
  article-title: Advances in surgery for movement disorders
  publication-title: Mov Disord
– volume: 76
  start-page: 1811
  issue: 21
  year: 2011
  end-page: 1816
  article-title: Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
  publication-title: Neurology
– volume: 76
  start-page: 759
  issue: 7
  year: 2016
  end-page: 777
  article-title: Drug‐induced dyskinesia, part 1: treatment of levodopa‐induced dyskinesia
  publication-title: Drugs
– volume: 30
  start-page: 244
  year: 2007
  end-page: 250
  article-title: Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
  publication-title: Trends Neurosci
– volume: 2
  start-page: a009258
  issue: 8
  year: 2012
  end-page: a009258
  article-title: Parkinson's disease and parkinsonism: neuropathology
  publication-title: Cold Spring Harb Perspect Med
– volume: 4
  start-page: 500
  year: 1984
  end-page: 506
  article-title: Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases
  publication-title: J Cereb Blood Flow Metab
– volume: 87
  start-page: 443
  issue: 4
  year: 2016
  end-page: 444
  article-title: MRI signs of multiple system atrophy preceding the clinical diagnosis: the case for an imaging‐supported probable MSA diagnostic category
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 375
  start-page: 730
  issue: 8
  year: 2016
  end-page: 739
  article-title: A randomized trial of focused ultrasound thalamotomy for essential tremor
  publication-title: N Engl J Med
– volume: 17
  start-page: 427
  issue: 5
  year: 1967
  end-page: 427
  article-title: Parkinsonism: onset, progression, and mortality
  publication-title: Neurology
– volume: 135
  start-page: 3699
  issue: 12
  year: 2012
  end-page: 3711
  article-title: Resting state functional connectivity of the striatum in Parkinson's disease
  publication-title: Brain
– volume: 52
  start-page: 848
  issue: 6
  year: 2011
  end-page: 855
  article-title: Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study
  publication-title: J Nuc Med
– volume: 110
  start-page: 3214
  issue: 9
  year: 2013
  end-page: 3215
  article-title: Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease
  publication-title: Proc Natl Acad Sci U S A
– volume: 9
  start-page: e89741
  issue: 2
  year: 2014
  article-title: Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients
  publication-title: PLoS ONE
– volume: 30
  start-page: 1442
  issue: 11
  year: 2015
  end-page: 1450
  article-title: Disease‐modifying strategies for Parkinson's disease
  publication-title: Mov Disord
– volume: 16
  start-page: 203
  issue: 1
  year: 2016
  end-page: 229
  article-title: Consensus paper: towards a systems‐level view of cerebellar function: the interplay between cerebellum, basal ganglia, and cortex
  publication-title: Cerebellum
– volume: 388
  start-page: 839
  issue: 6645
  year: 1997
  end-page: 840
  article-title: Alpha‐synuclein in Lewy bodies
  publication-title: Nature
– volume: 80
  start-page: 276
  issue: 3
  year: 2013
  end-page: 281
  article-title: The spectrum of nonmotor symptoms in early Parkinson disease: the ICICLE‐PD study
  publication-title: Neurology
– volume: 4
  start-page: 123
  issue: 1
  year: 1987
  end-page: 140
  article-title: Charcot, the clinician: the Tuesday lessons: excerpts from nine case presentations on general neurology delivered at the Salpêtrière Hospital in 1887‐88 by Jean‐Martin Charcot
  publication-title: Mov Disord
– volume: 30
  start-page: 780
  issue: 6
  year: 2015
  end-page: 785
  article-title: Parkinsonism following neuroleptic exposure: a double‐hit hypothesis?
  publication-title: Mov Disord
– volume: 10
  start-page: 12
  year: 2016
  article-title: Is alpha‐synuclein loss‐of‐function a contributor to parkinsonian pathology? Evidence from non‐human primates
  publication-title: Front Neurosci
– volume: 83
  start-page: 107
  year: 2007
  end-page: 128
  article-title: History of Parkinson's disease
  publication-title: Handb Clin Neurol
– volume: 26
  start-page: 775
  issue: 5
  year: 2011
  end-page: 783
  article-title: A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials
  publication-title: Mov Disord
– volume: 31
  start-page: 1095
  issue: 8
  year: 2016
  end-page: 1102
  article-title: Nonmotor features of Parkinson's disease subtypes
  publication-title: Mov Disord
– volume: 12
  start-page: 284
  issue: 5
  year: 2006
  end-page: 288
  article-title: Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
  publication-title: Parkinsonism Relat Disord
– volume: 26
  start-page: 1022
  issue: 6
  year: 2011
  end-page: 1031
  article-title: Parkinson's disease: the quintessential neuropsychiatric disorder
  publication-title: Mov Disord
– volume: 5
  start-page: 179
  year: 2012
  article-title: A role for locus coeruleus in Parkinson tremor
  publication-title: Front Hum Neurosci
– volume: 44
  start-page: 445
  year: 1940
  end-page: 459
  article-title: Surgical procedure for postencephalitic tremor, with notes on the physiology of the premotor fibers
  publication-title: Arch Neurol Psychiatry
– volume: 6
  start-page: 783
  issue: 11
  year: 1956
  end-page: 790
  article-title: Shift to older age distribution in parkinsonism: a report on 1,000 patients covering the past decade from three centers
  publication-title: Neurology
– volume: 79
  start-page: 2307
  issue: 24
  year: 2012
  end-page: 2314
  article-title: Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease
  publication-title: Neurology
– volume: 30
  start-page: 945
  issue: 7
  year: 2015
  end-page: 952
  article-title: Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease
  publication-title: Mov Disord
– volume: 24
  start-page: 197
  issue: 2
  year: 2003
  end-page: 211
  article-title: Staging of brain pathology related to sporadic Parkinson's disease
  publication-title: Neurobiol Aging
– volume: 7
  start-page: 117
  issue: 2
  year: 1992
  end-page: 124
  article-title: Levodopa‐induced dyskinesias in Parkinson's disease: clinical and pharmacological classification
  publication-title: Mov Disord
– volume: 70
  start-page: 1411
  issue: Pt 2
  year: 2008
  end-page: 1417
  article-title: Midbrain iron content in early Parkinson disease: A potential biomarker of disease status
  publication-title: Neurology
– volume: 104
  start-page: 1325
  issue: 4
  year: 2007
  end-page: 1330
  article-title: Progressive parkinsonism in mice with respiratory‐chain‐deficient dopamine neurons
  publication-title: Proc Natl Acad Sci U S A
– volume: 27
  start-page: 1276
  issue: 10
  year: 2012
  end-page: 1282
  article-title: Caffeine and risk of Parkinson's disease in a large cohort of men and women
  publication-title: Mov Disord
– volume: 30
  start-page: 80
  issue: 1
  year: 2014
  end-page: 89
  article-title: Clinical spectrum of levodopa‐induced complications
  publication-title: Mov Disord
– volume: 34
  start-page: 9441
  issue: 28
  year: 2014
  end-page: 9454
  article-title: Reducing C‐terminal‐truncated alpha‐synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease‐like models
  publication-title: J Neurosci
– volume: 128
  start-page: 2760
  issue: 12
  year: 2005
  end-page: 2762
  article-title: Genetics of Parkinson's disease: LRRK2 on the rise
  publication-title: Brain
– year: 1807
– volume: 138
  start-page: 2974
  issue: 10
  year: 2015
  end-page: 2986
  article-title: Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE‐PD study
  publication-title: Brain
– volume: 31
  start-page: 161
  issue: 2
  year: 2015
  end-page: 168
  article-title: Alpha‐synuclein propagation: new insights from animal models
  publication-title: Mov Disord
– volume: 29
  start-page: 454
  issue: 4
  year: 2014
  end-page: 462
  article-title: Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
  publication-title: Mov Disord
– volume: 127
  start-page: 2747
  issue: 12
  year: 2004
  end-page: 2754
  article-title: Levodopa‐induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias
  publication-title: Brain
– volume: 1
  start-page: 197
  year: 1824
  article-title: On the treatment of infectious or typhoid fever
  publication-title: Lond Med Repository
– volume: 340
  start-page: 125
  issue: 8811
  year: 1992
  end-page: 126
  article-title: Dopamine, tremor, and Parkinson's disease
  publication-title: Lancet
– volume: 85
  start-page: 1670
  issue: 19
  year: 2015
  end-page: 1679
  article-title: Parkinson disease and incidental Lewy body disease: just a question of time?
  publication-title: Neurology
– volume: 55
  start-page: 181
  issue: 3
  year: 1992
  end-page: 184
  article-title: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico‐pathological study of 100 cases
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 20
  start-page: 808
  issue: 8
  year: 2014
  end-page: 814
  article-title: Differentiating drug‐induced parkinsonism from Parkinson's disease: an update on non‐motor symptoms and investigations
  publication-title: Parkinsonism Relat Disord
– volume: 122
  start-page: 187
  issue: 2
  year: 2011
  end-page: 204
  article-title: Neuropathology underlying clinical variability in patients with synucleinopathies
  publication-title: Acta Neuropathol
– volume: 86
  start-page: 566
  issue: 6
  year: 2016
  end-page: 576
  article-title: Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta‐analysis
  publication-title: Neurology
– volume: 137
  start-page: 849
  issue: 3
  year: 2014
  end-page: 859
  article-title: Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations
  publication-title: Brain
– volume: 31
  start-page: 1623
  issue: 11
  year: 2016
  end-page: 1627
  article-title: Abolishing the 1‐year rule: how much evidence will be enough?
  publication-title: Mov Disord
– volume: 30
  start-page: 1079
  issue: 11
  year: 2016
  end-page: 1095
  article-title: Novel levodopa formulations for Parkinson's disease
  publication-title: CNS Drug
– volume: 56
  start-page: 1
  year: 1999
  end-page: 29
  article-title: Post mortem studies in Parkinson's disease—is it possible to detect brain areas for specific symptoms?
  publication-title: J Neural Transm
– volume: 12
  start-page: 747
  issue: 8
  year: 2013
  end-page: 755
  article-title: Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed‐start trial
  publication-title: Lancet Neurol
– volume: 32
  start-page: 64
  issue: 1
  year: 2016
  end-page: 69
  article-title: Oscillatory activity in the basal ganglia and deep brain stimulation
  publication-title: Mov Disord
– volume: 351
  start-page: 2498
  issue: 24
  year: 2004
  end-page: 2508
  article-title: Levodopa and the progression of Parkinson's disease
  publication-title: N Engl J Med
– volume: 32
  start-page: 346
  issue: 3
  year: 2017
  end-page: 363
  article-title: Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease
  publication-title: Mov Disord
– volume: 8
  start-page: e70244
  issue: 8
  year: 2013
  article-title: The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients
  publication-title: PLoS ONE
– volume: 8
  start-page: 59
  year: 1817
  end-page: 61
  article-title: Editor's note
  publication-title: Lond Med Repository
– volume: 14
  start-page: 501
  issue: 12
  year: 2014
  article-title: Imaging the aetiology of sleep disorders in dementia and Parkinson's disease
  publication-title: Curr Neurol Neurosci Rep
– volume: 140
  start-page: 394
  issue: 3565
  year: 1963
  end-page: 396
  article-title: Intracranial self‐stimulation in man
  publication-title: Science
– volume: 124
  start-page: 1340
  issue: 3
  year: 2014
  end-page: 1349
  article-title: Serotonergic mechanisms responsible for levodopa‐induced dyskinesias in Parkinson's disease patients
  publication-title: J Clin Invest
– volume: 47
  start-page: 1
  issue: 1
  year: 1996
  end-page: 9
  article-title: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele‐Richardson‐Olszewski syndrome): report of the NINDS‐SPSP International Workshop
  publication-title: Neurology
– volume: 27
  start-page: 8
  issue: 1
  year: 2011
  end-page: 30
  article-title: Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts
  publication-title: Mov Disord
– volume: 30
  start-page: 886
  issue: 7
  year: 2015
  end-page: 894
  article-title: Vascular parkinsonism: deconstructing a syndrome
  publication-title: Mov Disord
– volume: 44
  start-page: 870
  issue: 6
  year: 2003
  end-page: 876
  article-title: Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I‐beta‐CIT SPECT
  publication-title: J Nucl Med
– volume: 31
  start-page: 957
  issue: 7
  year: 2016
  end-page: 961
  article-title: Motor subtype in Parkinson's disease: different disorders or different stages of disease?
  publication-title: Mov Disord
– volume: 31
  start-page: 1283
  issue: 9
  year: 2016
  end-page: 1292
  article-title: New methods for the assessment of Parkinson's disease (2005 to 2015): a systematic review
  publication-title: Mov Disord
– volume: 79
  start-page: 940
  issue: 6
  year: 2016
  end-page: 949
  article-title: Pathological α‐synuclein in gastrointestinal tissues from prodromal Parkinson disease patients
  publication-title: Ann Neurol
– volume: 2
  start-page: 490
  year: 1789
  end-page: 500
  article-title: Some account of the effects of lightning
  publication-title: Mem M Soc Lon
– volume: 32
  year: 2017
  article-title: 200 years since James Parkinson's essay on “The Shaking Palsy” Have we made progress?
  publication-title: Mov Disord
– volume: 133
  start-page: 3423
  issue: 11
  year: 2010
  end-page: 3433
  article-title: Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature
  publication-title: Brain
– volume: 138
  start-page: 3003
  issue: 10
  year: 2015
  end-page: 3015
  article-title: Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease
  publication-title: Brain
– year: 1886
– volume: 89
  start-page: 162
  issue: 1
  year: 2011
  end-page: 167
  article-title: VPS35 mutations in Parkinson disease
  publication-title: Am J Hum Genet
– volume: 69
  start-page: 811
  issue: 5
  year: 2011
  end-page: 818
  article-title: Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder
  publication-title: Ann Neurol
– volume: 32
  start-page: 203
  issue: 2
  year: 2017
  end-page: 207
  article-title: Targeting α‐synuclein as a therapy for Parkinson's disease: the battle begins
  publication-title: Mov Disord
– volume: 6
  start-page: 286
  year: 2014
  article-title: Instrumented Functional Reach Test Differentiates Individuals at High Risk for Parkinsons™ disease from controls
  publication-title: Front Aging Neurosci
– volume: 72
  start-page: 57
  issue: 1
  year: 2011
  end-page: 71
  article-title: Exogenous α‐synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death
  publication-title: Neuron
– volume: 52
  start-page: 11
  issue: suppl.
  year: 1989
  end-page: 12
  article-title: Did parkinsonism occur before 1817?
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 25
  start-page: 1116
  issue: 9
  year: 2010
  end-page: 1123
  article-title: A historical analysis of the relationship between encephalitis lethargica and postencephalitic parkinsonism: a complex rather than a direct relationship
  publication-title: Mov Disord
– volume: 31
  start-page: 141
  issue: 4
  year: 2010
  end-page: 142
  article-title: Lessons from the rotenone model of Parkinson's disease
  publication-title: Trends Pharmacol Sci
– volume: 45
  start-page: 565
  issue: 3
  year: 1995
  end-page: 568
  article-title: An essay on Wilhelm von Humboldt and the shaking palsy: first comprehensive description of Parkinson's disease by a patient
  publication-title: Neurology
– volume: 46
  start-page: 989
  issue: 9
  year: 2014
  end-page: 993
  article-title: Large‐scale meta‐analysis of genome‐wide association data identifies six new risk loci for Parkinson's disease
  publication-title: Nat Genet
– volume: 83
  start-page: 386
  issue: 5
  year: 2014
  end-page: 387
  article-title: Accuracy of Parkinson disease diagnosis unchanged in 2 decades
  publication-title: Neurology
– volume: 16
  start-page: 32
  issue: 1
  year: 1959
  end-page: 54
  article-title: Early experiences with ultrasonic irradiation of the pallidofugal and nigral complexes in hyperkinetic and hypertonic disorders
  publication-title: J Neurosurg
– volume: 404
  start-page: 394
  issue: 6776
  year: 2000
  end-page: 398
  article-title: A drosophila model of Parkinson's disease
  publication-title: Nature
– volume: 83
  start-page: 208
  issue: 3
  year: 2014
  end-page: 214
  article-title: Functional connectivity in the basal ganglia network differentiates PD patients from controls
  publication-title: Neurology
– volume: 162
  start-page: 1418
  issue: 6
  year: 2015
  end-page: 1430
  article-title: Dopamine is required for the neural representation and control of movement vigor
  publication-title: Cell
– volume: 30
  start-page: 1862
  issue: 1
  year: 2015
  end-page: 1869
  article-title: Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions
  publication-title: Mov Disord
– volume: 31
  start-page: 436
  issue: 4
  year: 2016
  end-page: 457
  article-title: Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society Task Force
  publication-title: Mov Disord
– year: 1877
– volume: 60
  start-page: 1331
  issue: 2
  year: 2012
  end-page: 1339
  article-title: Oscillating central motor networks in pathological tremors and voluntary movements. What makes the difference?
  publication-title: NeuroImage
– volume: 64
  start-page: S101
  issue: S2
  year: 2009
  end-page: S110
  article-title: Why have we failed to achieve neuroprotection in Parkinson's disease?
  publication-title: Ann Neurol
– volume: 3
  start-page: 481
  year: 2013
  end-page: 488
  article-title: Diffusion tensor imaging of nigral degeneration in Parkinson's disease: a region‐of‐interest and voxel‐based study at 3T and systematic review with meta‐analysis
  publication-title: NeuroImage Clin
– volume: 32
  year: 2017
  article-title: The emerging science of precision medicine and pharmacogenomics for Parkinson's disease
  publication-title: Mov Disord
– volume: 5
  start-page: 3
  issue: 1
  year: 2015
  end-page: 10
  article-title: Coffee, genetic variants, and Parkinson's disease: gene–environment interactions
  publication-title: J Caffeine Res
– volume: 71
  start-page: 141
  issue: 2
  year: 2014
  end-page: 150
  article-title: Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial
  publication-title: JAMA Neurol
– volume: 30
  start-page: 1591
  issue: 12
  year: 2015
  end-page: 1601
  article-title: MDS clinical diagnostic criteria for Parkinson's disease
  publication-title: Mov Disord
– volume: 130
  start-page: 2123
  issue: 8
  year: 2007
  end-page: 2128
  article-title: Patterns of levodopa response in Parkinson's disease: a clinico‐pathological study
  publication-title: Brain
– volume: 32
  start-page: 20
  year: 2017
  end-page: 27
  article-title: Focus ultrasound therapy for movement disorders: current data and expected developments
  publication-title: Mov Disord
– volume: 361
  start-page: 1268
  issue: 13
  year: 2009
  end-page: 1278
  article-title: A double‐blind, delayed‐start trial of rasagiline in Parkinson's disease
  publication-title: N Engl J Med
– volume: 31
  start-page: 152
  issue: 2
  year: 2015
  end-page: 160
  article-title: Neuropathology of α‐synuclein propagation and braak hypothesis
  publication-title: Mov Disord
– volume: 28
  start-page: 96
  issue: 1
  year: 2013
  end-page: 109
  article-title: Trophic factor gene therapy for Parkinson's disease
  publication-title: Mov Disord
– volume: 23
  start-page: 474
  year: 2008
  end-page: 483
  article-title: Glial reactions in Parkinson's disease
  publication-title: Mov Disord
– volume: 72
  start-page: 863
  issue: 8
  year: 2015
  end-page: 873
  article-title: New clinical subtypes of Parkinson disease and their longitudinal progression
  publication-title: JAMA Neurol
– volume: 30
  start-page: 998
  issue: suppl. 1
  year: 2015
– volume: 72
  start-page: 886
  issue: 10
  year: 2008
  end-page: 892
  article-title: A controlled trial of antidepressants in patients with Parkinson disease and depression
  publication-title: Neurology
– volume: 138
  start-page: 2322
  issue: 8
  year: 2015
  end-page: 2331
  article-title: Longitudinal changes in free‐water within the substantia nigra of Parkinson's disease
  publication-title: Brain
– volume: 80
  start-page: 2035
  issue: 22
  year: 2013
  end-page: 2041
  article-title: Exposure to pesticides or solvents and risk of Parkinson disease
  publication-title: Neurology
– volume: 77
  start-page: 406
  issue: 3
  year: 2013
  end-page: 424
  article-title: Probing and regulating dysfunctional circuits using deep brain stimulation
  publication-title: Neuron
– volume: 32
  start-page: 115
  issue: 1
  year: 2016
  end-page: 123
  article-title: Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration
  publication-title: Mov Disord
– volume: 27
  start-page: 913
  issue: 7
  year: 2012
  end-page: 916
  article-title: A single‐question screen for rapid eye movement sleep behavior disorder: a multicenter validation study
  publication-title: Mov Disord
– volume: 16
  start-page: 629
  issue: 6
  year: 2006
  end-page: 637
  article-title: Basal ganglia oscillations and pathophysiology of movement disorders
  publication-title: Curr Opin Neurobiol
– volume: 69
  start-page: 803
  issue: 5
  year: 2011
  end-page: 810
  article-title: Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease
  publication-title: Ann Neurol
– volume: 17
  start-page: 251
  issue: 4
  year: 2016
  end-page: 260
  article-title: A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration
  publication-title: Nat Rev Neurosci
– volume: 24
  start-page: R32
  issue: R1
  year: 2015
  end-page: R44
  article-title: Pathways to parkinsonism redux: convergent pathobiological mechanisms in genetics of Parkinson's disease
  publication-title: Hum Mol Genet
– volume: 302
  start-page: 841
  issue: 5646
  year: 2003
  article-title: Alpha‐synuclein locus triplication causes Parkinson's disease
  publication-title: Science
– volume: 29
  start-page: 1767
  issue: 14
  year: 2014
  end-page: 1773
  article-title: Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts
  publication-title: Mov Disord
– volume: 219
  start-page: 979
  issue: 4587
  year: 1983
  end-page: 980
  article-title: Chronic Parkinsonism in humans due to a product of meperidine‐analog synthesis
  publication-title: Science
– volume: 85
  start-page: 770
  issue: 7
  year: 2014
  end-page: 881
  article-title: A practical approach to diagnosing adult onset leukodystrophies
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 83
  start-page: 2046
  issue: 22
  year: 2014
  end-page: 2053
  article-title: Functional connectivity and cognitive decline over 3 years in Parkinson disease
  publication-title: Neurology
– volume: 7
  start-page: 400
  issue: 5
  year: 2008
  end-page: 408
  article-title: Safety and tolerability of intraputaminal delivery of CERE‐120 (adeno‐associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open‐label, phase I trial
  publication-title: Lancet Neurol
– volume: 13
  start-page: 2
  issue: S3
  year: 2008
  end-page: 23
  article-title: Consensus statement of the Movement Disorder Society on tremor
  publication-title: Mov Disord
– volume: 155
  start-page: 96
  year: 2017
  end-page: 119
  article-title: Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
  publication-title: Prog Neurobiol
– volume: 136
  start-page: 2120
  issue: 7
  year: 2013
  end-page: 2129
  article-title: The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease
  publication-title: Brain
– volume: 86
  start-page: S3
  issue: 14 suppl. 1
  year: 2016
  end-page: S12
  article-title: Levodopa therapy for Parkinson disease: a look backward and forward
  publication-title: Neurology
– volume: 119
  start-page: 689
  issue: 6
  year: 2010
  end-page: 702
  article-title: Multi‐organ distribution of phosphorylated α‐synuclein histopathology in subjects with Lewy body disorders
  publication-title: Acta Neuropathol
– volume: 31
  start-page: 405
  issue: 3
  year: 2016
  end-page: 409
  article-title: A scan without evidence is not evidence of absence: scans without evidence of dopaminergic deficit in a symptomatic leucine‐rich repeat kinase 2 mutation carrier
  publication-title: Mov Disord
– volume: 75
  start-page: 857
  issue: 10
  year: 2010
  end-page: 863
  article-title: Regional patterns of brain tissue loss associated with depression in Parkinson disease
  publication-title: Neurology
– volume: 79
  start-page: 402
  issue: 5
  year: 2016
  end-page: 414
  article-title: Alpha‐synuclein produces early behavioral alterations via striatal cholinergic synaptic dysfunction by interacting with GluN2D N‐methyl‐D‐aspartate receptor subunit
  publication-title: Biol Psychiatry
– volume: 29
  start-page: 1820
  issue: 14
  year: 2014
  end-page: 1825
  article-title: Patients with scans without evidence of dopaminergic deficit: a long‐term follow‐up study
  publication-title: Mov Disord
– volume: 276
  start-page: 2045
  issue: 5321
  year: 1997
  end-page: 2047
  article-title: Mutation in the a‐synuclein gene identified in families with Parkinson's disease
  publication-title: Science
– volume: 39
  start-page: 750
  issue: 11
  year: 2016
  end-page: 762
  article-title: α‐synuclein‐based animal models of Parkinson's disease: challenges and opportunities in a new era
  publication-title: Trends Neurosci
– volume: 8
  start-page: 5
  year: 2014
  article-title: The thalamostriatal system in normal and diseased states
  publication-title: Front Syst Neurosci
– volume: 76
  start-page: 53
  issue: 1
  year: 1992
  end-page: 61
  article-title: Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease
  publication-title: J Neurosurg
– volume: 34
  start-page: 284
  year: 2008
  end-page: 295
  article-title: The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein staging
  publication-title: Neuropathol Appl Neurobiol
– volume: 20
  start-page: 8559
  issue: 22
  year: 2000
  end-page: 8571
  article-title: Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine vervet model of parkinsonism
  publication-title: J Neurosci
– volume: 27
  start-page: 656
  issue: 5
  year: 2012
  end-page: 665
  article-title: Defining at‐risk populations for Parkinson's disease: lessons from ongoing studies
  publication-title: Mov Disord
– volume: 83
  start-page: 1739
  issue: 19
  year: 2014
  end-page: 1746
  article-title: Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study
  publication-title: Neurology
– volume: 69
  start-page: 269
  issue: 2
  year: 2011
  end-page: 281
  article-title: Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor
  publication-title: Ann Neurol
– volume: 7
  start-page: 299
  issue: 6
  year: 1988
  end-page: 305
  article-title: Lewy body disease with and without dementia: a clinicopathological study of 35 cases
  publication-title: Clin Neuropathol
– volume: 79
  start-page: 991
  issue: 6
  year: 2016
  end-page: 999
  article-title: α‐synuclein genetic variability: a biomarker for dementia in Parkinson disease
  publication-title: Ann Neurol
– volume: 39
  start-page: 37
  issue: 1
  year: 1996
  end-page: 45
  article-title: Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa
  publication-title: Ann Neurol
– volume: 138
  start-page: 2964
  issue: 10
  year: 2015
  end-page: 2973
  article-title: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease
  publication-title: Brain
– volume: 24
  start-page: 869
  issue: 8
  year: 2004
  end-page: 876
  article-title: Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease‐compensatory mechanisms
  publication-title: J Cereb Blood Flow Metab
– volume: 276
  start-page: 374
  issue: 7
  year: 1967
  end-page: 379
  article-title: Aromatic amino acids and modification of parkinsonism
  publication-title: N Engl J Med
– volume: 31
  start-page: 861
  issue: 6
  year: 2016
  end-page: 881
  article-title: Biomarkers for dementia and mild cognitive impairment in Parkinson's disease
  publication-title: Mov Disord
– volume: 34
  start-page: 254
  issue: 1
  year: 2009
  article-title: Lewy body pathology in long‐term fetal nigral transplants: is Parkinson's disease transmitted from one neural system to another?
  publication-title: Neuropsychopharmacology
– volume: 71
  start-page: 670
  issue: 9
  year: 2008
  end-page: 676
  article-title: Second consensus statement on the diagnosis of multiple system atrophy
  publication-title: Neurology
– volume: 149
  start-page: 175
  issue: 3
  year: 1993
  end-page: 176
  article-title: [Effects of the stimulation of the subthalamic nucleus in Parkinson disease]
  publication-title: Rev Neurol (Paris)
– volume: 51
  start-page: 745
  issue: 6
  year: 1988
  end-page: 752
  article-title: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 15
  start-page: 708
  issue: 7
  year: 2016
  end-page: 718
  article-title: Assessment of α‐synuclein in submandibular glands of patients with idiopathic rapid‐eye‐movement sleep behaviour disorder: a case‐control study
  publication-title: Lancet Neurol
– volume: 78
  start-page: 248
  issue: 2
  year: 2015
  end-page: 257
  article-title: Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: a double‐blind, randomized, controlled trial
  publication-title: Ann Neurol
– volume: 260
  start-page: 1009
  issue: 4
  year: 2013
  end-page: 1013
  article-title: Normal pressure hydrocephalus or progressive supranuclear palsy? A clinicopathological case series
  publication-title: J Neurol
– volume: 338
  start-page: 949
  issue: 6109
  year: 2012
  end-page: 953
  article-title: Pathological alpha‐synuclein transmission initiates parkinson‐like neurodegeneration in nontransgenic mice
  publication-title: Science
– volume: 62
  start-page: 218
  issue: 2
  year: 2009
  end-page: 229
  article-title: Interplay between cytosolic dopamine, calcium, and α‐synuclein causes selective death of substantia nigra neurons
  publication-title: Neuron
– volume: 27
  start-page: 716
  issue: 6
  year: 2012
  end-page: 719
  article-title: Is alpha‐synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases
  publication-title: Mov Disord
– volume: 46
  start-page: 419
  issue: 3
  year: 1999
  end-page: 424
  article-title: Clinicopathological findings following intraventricular glial‐derived neurotrophic factor treatment in a patient with Parkinson's disease
  publication-title: Ann Neurol
– volume: 79
  start-page: 1331
  issue: 12
  year: 2008
  end-page: 1338
  article-title: Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 44
  start-page: 595
  issue: 4
  year: 2004
  end-page: 600
  article-title: Cloning of the gene containing mutations that cause PARK8‐linked Parkinson's disease
  publication-title: Neuron
– volume: 31
  start-page: 203
  issue: 2
  year: 2015
  end-page: 213
  article-title: Development of passive Immunotherapies for synucleinopathies
  publication-title: Mov Disord
– volume: 12
  start-page: 462
  issue: 5
  year: 2013
  end-page: 468
  article-title: MR‐guided focused ultrasound thalamotomy for essential tremor: a proof‐of‐concept study
  publication-title: Lancet Neurol
– volume: 32
  start-page: 36
  issue: 1
  year: 2017
  end-page: 52
  article-title: Current applications and limitations of surgical treatments for movement disorders
  publication-title: Mov Disord
– volume: 17
  start-page: 895
  issue: 7
  year: 2016
  end-page: 909
  article-title: New and emerging medical therapies in Parkinson's disease
  publication-title: Expert Opin Pharmacother
– volume: 37
  start-page: 313
  issue: 03
  year: 2010
  end-page: 319
  article-title: Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship
  publication-title: Can J Neurol Sci
– volume: 31
  start-page: 45
  year: 2016
  end-page: 52
  article-title: Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase
  publication-title: Mov Disord
– volume: 5
  start-page: 107
  issue: 1
  year: 1968
  end-page: 110
  article-title: 6‐hydroxy‐dopamine induced degeneration of central monoamine neurons
  publication-title: Eur J Pharmacol
– volume: 72
  start-page: 455
  issue: 3
  year: 2012
  end-page: 463
  article-title: Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
  publication-title: Ann Neurol
– volume: 383
  start-page: 533
  year: 2014
  end-page: 540
  article-title: Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo‐controlled phase 3 trial
  publication-title: Lancet
– volume: 136
  start-page: 710
  issue: 3
  year: 2013
  end-page: 725
  article-title: Rhythm‐specific modulation of the sensorimotor network in drug‐naïve patients with Parkinson's disease by levodopa
  publication-title: Brain
– volume: 27
  start-page: 317
  issue: 2
  year: 1953
  end-page: 319
  article-title: Ligation of the anterior choroidal artery for involuntary movements; parkinsonism
  publication-title: Psychiatr Q
– year: 1804
– volume: 318
  start-page: 311
  issue: 7179
  year: 1999
  end-page: 314
  article-title: Science, medicine, and the future: Parkinson's disease
  publication-title: BMJ
– volume: 12
  start-page: 1068
  issue: 6
  year: 1997
  end-page: 1072
  article-title: The shaking palsy, the first forty‐five years: a journey through the British literature
  publication-title: Mov Disord
– volume: 44
  start-page: 601
  issue: 4
  year: 2004
  end-page: 607
  article-title: Mutations in LRRK2 cause autosomal‐dominant parkinsonism with pleomorphic pathology
  publication-title: Neuron
– volume: 114
  start-page: 2283
  issue: 5
  year: 1991
  end-page: 2301
  article-title: Ageing and Parkinson's disease: substantia nigra regional selectivity
  publication-title: Brain
– volume: 789
  start-page: 9
  issue: 1
  year: 1998
  end-page: 22
  article-title: Topographical distribution of [125I]‐glial cell line‐derived neurotrophic factor in unlesioned and MPTP‐lesioned rhesus monkey brain following a bolus intraventricular injection
  publication-title: Brain Res
– volume: 77
  start-page: 1357
  issue: 14
  year: 2011
  end-page: 1362
  article-title: Mild cognitive impairment in drug‐naive patients with PD is associated with cerebral hypometabolism
  publication-title: Neurology
– volume: 106
  start-page: 20051
  issue: 47
  year: 2009
  end-page: 20056
  article-title: Exogenous alpha‐synuclein fibrils seed the formation of Lewy body‐like intracellular inclusions in cultured cells
  publication-title: Proc Natl Acad Sci U S A
– volume: 70
  start-page: 1033
  issue: 6
  year: 2011
  end-page: 1053
  article-title: Mitochondria: the next (neurode) generation
  publication-title: Neuron
– volume: 128
  start-page: 1314
  issue: 6
  year: 2005
  end-page: 1322
  article-title: Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system
  publication-title: Brain
– volume: 85
  start-page: 1362
  issue: 16
  year: 2015
  end-page: 1367
  article-title: Clinical implications of delayed orthostatic hypotension
  publication-title: Neurology
– volume: 34
  start-page: 35
  issue: 1
  year: 2013
  end-page: 61
  article-title: Advancing neurotrophic factors as treatments for age‐related neurodegenerative diseases: developing and demonstrating “clinical proof‐of‐concept” for AAV‐neurturin (CERE‐120) in Parkinson's disease
  publication-title: Neurobiol Aging
– volume: 14
  start-page: 975
  issue: 10
  year: 2015
  end-page: 976
  article-title: Multitarget disease‐modifying therapy in Parkinson's disease?
  publication-title: Lancet Neurol
– volume: 400
  start-page: 677
  issue: 6745
  year: 1999
  end-page: 682
  article-title: A basal ganglia pacemaker formed by the subthalamic nucleus and dexternal globus pallidus
  publication-title: Nature
– volume: 30
  start-page: 747
  issue: 6
  year: 2015
  end-page: 749
  article-title: Genetic risk loci for Parkinson's disease: moving from state to trait?
  publication-title: Mov Disord
– volume: 42
  start-page: 720
  issue: 5
  year: 1997
  end-page: 726
  article-title: Alterations in opioid receptor binding in Parkinson's disease patients with levodopa‐induced dyskinesias
  publication-title: Ann Neurol
– volume: 7
  start-page: 583
  issue: 7
  year: 2008
  end-page: 590
  article-title: Phenotype, genotype, and worldwide genetic penetrance of LRRK2‐associated Parkinson's disease: a case‐control study
  publication-title: Lancet Neurol
– volume: 55
  start-page: 761
  issue: 6
  year: 2004
  end-page: 765
  article-title: Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease
  publication-title: Ann Neurol
– volume: 14
  start-page: 504
  issue: 5
  year: 2008
  end-page: 506
  article-title: Lewy body–like pathology in long‐term embryonic nigral transplants in Parkinson's disease
  publication-title: Nat Med
– volume: 31
  start-page: 1748
  issue: 11
  year: 2016
  end-page: 1751
  article-title: Subthalamic synchronized oscillatory activity correlates with motor impairment in patients with Parkinson's disease
  publication-title: Mov Disord
– volume: 90
  start-page: 675
  issue: 4
  year: 2016
  end-page: 691
  article-title: Understanding dopaminergic cell death pathways in Parkinson disease
  publication-title: Neuron
– volume: 28
  start-page: 447
  issue: 4
  year: 2012
  end-page: 454
  article-title: Parkinson's disease patients show reduced cortical‐subcortical sensorimotor connectivity
  publication-title: Mov Disord
– volume: 59
  start-page: 459
  issue: 3
  year: 2007
  end-page: 466
  article-title: Randomized controlled trial of intraputamenal glial cell line‐derived neurotrophic factor infusion in Parkinson disease
  publication-title: Ann Neurol
– volume: 287
  start-page: 1265
  issue: 5456
  year: 2000
  end-page: 1269
  article-title: Dopaminergic loss and inclusion body formation in alpha‐synuclein mice: implications for neurodegenerative disorders
  publication-title: Science
– volume: 290
  start-page: 767
  issue: 5492
  year: 2000
  end-page: 773
  article-title: Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
  publication-title: Science
– volume: 30
  start-page: 4
  issue: 1
  year: 2014
  end-page: 18
  article-title: The medical treatment of Parkinson disease from James Parkinson to George Cotzias
  publication-title: Mov Disord
– volume: 77
  start-page: 830
  issue: 5
  year: 2015
  end-page: 839
  article-title: Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study
  publication-title: Ann Neurol
– year: 1833
– volume: 27
  start-page: 349
  issue: 3
  year: 2012
  end-page: 356
  article-title: Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
  publication-title: Mov Disord
– volume: 31
  start-page: 458
  issue: 4
  year: 2016
  end-page: 470
  article-title: Genetics of movement disorders in the next‐generation sequencing era
  publication-title: Mov Disord
– volume: 384
  start-page: 545
  issue: 9942
  year: 2014
  end-page: 555
  article-title: Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
  publication-title: Lancet
– volume: 65
  start-page: 1442
  issue: 9
  year: 2005
  end-page: 1446
  article-title: Excessive daytime sleepiness and subsequent development of Parkinson disease
  publication-title: Neurology
– volume: 78
  start-page: 1229
  year: 2012
  end-page: 1236
  article-title: A randomized, double‐blind, placebo‐controlled trial of antidepressants in Parkinson's disease
  publication-title: Neurology
– volume: 27
  start-page: 276
  issue: 3
  year: 1990
  end-page: 282
  article-title: A large kindred with autosomal dominant Parkinson's disease
  publication-title: Ann Neurol
– volume: 65
  start-page: 1716
  issue: 11
  year: 2005
  end-page: 1722
  article-title: Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways
  publication-title: Neurology
– volume: 242
  start-page: 1654
  issue: 4886
  year: 1988
  end-page: 1664
  article-title: The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function
  publication-title: Science
– volume: 5
  start-page: 162
  issue: 2
  year: 1990
  end-page: 166
  article-title: An essay on the shaking palsy: reviews and notes on the journals in which they appeared
  publication-title: Mov Disord
– volume: 70
  start-page: 571
  issue: 5
  year: 2013
  end-page: 579
  article-title: Parkin disease: a clinicopathologic entity?
  publication-title: JAMA Neurology
– volume: 67
  start-page: 58
  issue: 1
  year: 2010
  end-page: 63
  article-title: Dopamine agonist withdrawal syndrome in Parkinson Disease
  publication-title: Arch Neurol
– volume: 30
  start-page: 1521
  issue: 11
  year: 2015
  end-page: 1527
  article-title: Basic science breaks through: New therapeutic advances in Parkinson's disease
  publication-title: Mov Disord
– volume: 75
  start-page: 1920
  issue: 21
  year: 2010
  end-page: 1927
  article-title: Depressive symptoms in PD correlate with higher 5‐HTT binding in raphe and limbic structures
  publication-title: Neurology
– year: 2017
  article-title: Mild cognitive impairment as a risk factor for Parkinson's disease dementia
  publication-title: Mov Disord
– volume: 256
  start-page: 21
  year: 2014
  end-page: 24
  article-title: Rebuilding the nigrostriatal dopamine pathway: 30 years and counting
  publication-title: Exp Neurol
– ident: e_1_2_8_24_1
  doi: 10.1002/ana.20102
– ident: e_1_2_8_148_1
  doi: 10.1016/j.jalz.2014.04.014
– ident: e_1_2_8_69_1
  doi: 10.1016/j.neuron.2016.03.038
– ident: e_1_2_8_101_1
  doi: 10.1007/s12311-016-0763-3
– ident: e_1_2_8_288_1
  doi: 10.1002/mds.26481
– ident: e_1_2_8_231_1
  doi: 10.1212/01.wnl.0000183056.89590.0d
– ident: e_1_2_8_105_1
  doi: 10.1212/WNL.0000000000001020
– ident: e_1_2_8_179_1
  doi: 10.1002/mds.26125
– ident: e_1_2_8_227_1
  doi: 10.1002/mds.25037
– ident: e_1_2_8_222_1
  doi: 10.1093/brain/aws093
– ident: e_1_2_8_20_1
  doi: 10.1002/mds.26077
– ident: e_1_2_8_48_1
  doi: 10.1002/mds.23664
– ident: e_1_2_8_121_1
  doi: 10.1002/mds.21956
– ident: e_1_2_8_141_1
  doi: 10.1093/brain/awv093
– volume-title: Observations on the Nature and Cure of Gout
  year: 1805
  ident: e_1_2_8_7_1
– ident: e_1_2_8_176_1
  doi: 10.1056/NEJMoa033447
– ident: e_1_2_8_184_1
  doi: 10.3171/jns.1958.15.3.0244
– ident: e_1_2_8_36_1
  doi: 10.1002/mds.26796
– ident: e_1_2_8_166_1
  doi: 10.1038/ng.3043
– ident: e_1_2_8_214_1
  doi: 10.1002/mds.26615
– ident: e_1_2_8_93_1
  doi: 10.1002/ana.22592
– ident: e_1_2_8_68_1
  doi: 10.1212/WNL.0000000000002102
– ident: e_1_2_8_215_1
  doi: 10.1002/mds.22908
– volume-title: Dangerous Sports: A Tale
  year: 1807
  ident: e_1_2_8_5_1
– ident: e_1_2_8_170_1
  doi: 10.1056/NEJM196702162760703
– ident: e_1_2_8_234_1
  doi: 10.1212/WNL.0000000000001684
– ident: e_1_2_8_250_1
  doi: 10.1016/j.neurobiolaging.2004.11.008
– volume: 2
  start-page: 490
  year: 1789
  ident: e_1_2_8_6_1
  article-title: Some account of the effects of lightning
  publication-title: Mem M Soc Lon
– volume-title: An Essay on the Shaking Palsy
  year: 1817
  ident: e_1_2_8_10_1
– ident: e_1_2_8_262_1
  doi: 10.1038/nm1746
– ident: e_1_2_8_173_1
  doi: 10.1007/s40263-016-0386-8
– ident: e_1_2_8_225_1
  doi: 10.3389/fnagi.2014.00286
– ident: e_1_2_8_253_1
  doi: 10.1111/j.1365-2990.2007.00923.x
– ident: e_1_2_8_159_1
  doi: 10.1016/j.neuron.2004.10.023
– ident: e_1_2_8_275_1
  doi: 10.1016/S1474-4422(13)70117-0
– ident: e_1_2_8_197_1
  doi: 10.1136/jnnp.55.3.181
– ident: e_1_2_8_100_1
  doi: 10.1002/ana.22361
– ident: e_1_2_8_230_1
  doi: 10.1371/journal.pone.0089741
– ident: e_1_2_8_113_1
  doi: 10.1093/brain/awp209
– ident: e_1_2_8_221_1
  doi: 10.1093/brain/114.5.2283
– ident: e_1_2_8_271_1
  doi: 10.1136/bmj.318.7179.311
– ident: e_1_2_8_217_1
  doi: 10.1002/mds.26246
– ident: e_1_2_8_296_1
  doi: 10.1002/ana.21461
– ident: e_1_2_8_190_1
  doi: 10.1016/j.neuron.2013.01.020
– ident: e_1_2_8_34_1
  doi: 10.1212/WNL.0000000000002350
– ident: e_1_2_8_156_1
  doi: 10.1101/cshperspect.a024109
– ident: e_1_2_8_120_1
  doi: 10.1093/brain/awv219
– ident: e_1_2_8_31_1
  doi: 10.1002/mds.26192
– ident: e_1_2_8_172_1
  doi: 10.1517/14656566.2016.1149163
– ident: e_1_2_8_177_1
  doi: 10.1002/mds.26445
– ident: e_1_2_8_82_1
  doi: 10.1126/science.287.5456.1265
– ident: e_1_2_8_19_1
  doi: 10.1212/WNL.45.3.565
– ident: e_1_2_8_175_1
  doi: 10.1002/mds.26119
– ident: e_1_2_8_183_1
  doi: 10.1007/BF01562492
– volume: 32
  year: 2017
  ident: e_1_2_8_299_1
  article-title: 200 years since James Parkinson's essay on “The Shaking Palsy” Have we made progress?
  publication-title: Mov Disord
– ident: e_1_2_8_232_1
  doi: 10.1002/ana.22282
– ident: e_1_2_8_207_1
  doi: 10.1016/j.conb.2006.10.002
– ident: e_1_2_8_209_1
  doi: 10.1016/S0306-4522(97)00295-9
– ident: e_1_2_8_269_1
  doi: 10.1002/mds.25373
– volume-title: A Manual of Diseases of the Nervous System
  year: 1886
  ident: e_1_2_8_22_1
– ident: e_1_2_8_102_1
  doi: 10.1093/brain/awt152
– ident: e_1_2_8_270_1
  doi: 10.1002/mds.26935
– ident: e_1_2_8_139_1
  doi: 10.1002/mds.26759
– ident: e_1_2_8_81_1
  doi: 10.1038/35006074
– ident: e_1_2_8_96_1
  doi: 10.1093/brain/aws281
– volume: 23
  start-page: 4012
  issue: 10
  year: 2003
  ident: e_1_2_8_211_1
  article-title: Functional correlations between neighboring neurons in the primate globus pallidus are weak or nonexistent
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-10-04012.2003
– ident: e_1_2_8_149_1
  doi: 10.1146/annurev-pharmtox-011613-135937
– ident: e_1_2_8_196_1
  doi: 10.1212/01.wnl.0000242888.30755.5d
– ident: e_1_2_8_91_1
  doi: 10.1093/brain/awv136
– ident: e_1_2_8_233_1
  doi: 10.1212/WNL.0000000000002030
– ident: e_1_2_8_260_1
  doi: 10.1002/mds.21751
– ident: e_1_2_8_114_1
  doi: 10.1002/ana.22284
– ident: e_1_2_8_163_1
  doi: 10.1016/j.ajhg.2011.06.001
– ident: e_1_2_8_247_1
  doi: 10.1002/mds.26477
– ident: e_1_2_8_146_1
  doi: 10.1002/ana.410270309
– ident: e_1_2_8_300_1
  doi: 10.1002/mds.27099
– ident: e_1_2_8_25_1
  doi: 10.1002/mds.23609
– ident: e_1_2_8_55_1
  doi: 10.1212/01.wnl.0000336340.89821.b3
– ident: e_1_2_8_50_1
  doi: 10.1002/mds.27002
– ident: e_1_2_8_23_1
  doi: 10.1212/WNL.6.11.783
– ident: e_1_2_8_128_1
  doi: 10.1212/01.wnl.0000191154.78131.f6
– volume: 7
  start-page: 299
  issue: 6
  year: 1988
  ident: e_1_2_8_74_1
  article-title: Lewy body disease with and without dementia: a clinicopathological study of 35 cases
  publication-title: Clin Neuropathol
– ident: e_1_2_8_103_1
  doi: 10.1093/brain/awv211
– ident: e_1_2_8_259_1
  doi: 10.1016/j.neuron.2009.01.033
– ident: e_1_2_8_71_1
  doi: 10.1002/mds.26354
– ident: e_1_2_8_229_1
  doi: 10.1016/j.sleep.2012.10.009
– ident: e_1_2_8_17_1
  doi: 10.1136/jnnp.51.6.745
– ident: e_1_2_8_21_1
  doi: 10.1212/WNL.17.5.427
– ident: e_1_2_8_44_1
  doi: 10.1016/j.parkreldis.2014.05.011
– ident: e_1_2_8_89_1
  doi: 10.1212/01.wnl.0000286384.31050.b5
– ident: e_1_2_8_117_1
  doi: 10.1172/JCI71640
– ident: e_1_2_8_95_1
  doi: 10.1093/brain/awq212
– ident: e_1_2_8_223_1
  doi: 10.1007/s00401-010-0664-3
– volume: 1
  start-page: 197
  year: 1824
  ident: e_1_2_8_8_1
  article-title: On the treatment of infectious or typhoid fever
  publication-title: Lond Med Repository
– ident: e_1_2_8_90_1
  doi: 10.1016/j.nicl.2013.10.006
– ident: e_1_2_8_178_1
  doi: 10.1007/s40265-016-0566-3
– ident: e_1_2_8_147_1
  doi: 10.1212/WNL.0b013e318294b3c8
– ident: e_1_2_8_136_1
  doi: 10.1016/0166-2236(90)90109-N
– ident: e_1_2_8_200_1
  doi: 10.1007/978-3-7091-6360-3_1
– ident: e_1_2_8_285_1
  doi: 10.1002/ana.24436
– ident: e_1_2_8_143_1
  doi: 10.3389/fnsys.2014.00005
– ident: e_1_2_8_144_1
  doi: 10.1159/000449011
– ident: e_1_2_8_97_1
  doi: 10.1093/brain/awt007
– ident: e_1_2_8_145_1
  doi: 10.1016/j.cell.2015.08.014
– volume: 4
  start-page: 123
  issue: 1
  year: 1987
  ident: e_1_2_8_14_1
  article-title: Charcot, the clinician: the Tuesday lessons: excerpts from nine case presentations on general neurology delivered at the Salpêtrière Hospital in 1887‐88 by Jean‐Martin Charcot
  publication-title: Mov Disord
– ident: e_1_2_8_111_1
  doi: 10.1002/mds.25975
– ident: e_1_2_8_151_1
  doi: 10.1002/mds.25217
– ident: e_1_2_8_134_1
  doi: 10.1016/j.parkreldis.2005.12.008
– ident: e_1_2_8_109_1
  doi: 10.1016/S1474-4422(11)70152-1
– ident: e_1_2_8_168_1
  doi: 10.1126/science.1218632
– ident: e_1_2_8_282_1
  doi: 10.1002/ana.20737
– ident: e_1_2_8_286_1
  doi: 10.1002/mds.26370
– ident: e_1_2_8_290_1
  doi: 10.1523/JNEUROSCI.5314-13.2014
– ident: e_1_2_8_203_1
  doi: 10.1523/JNEUROSCI.20-22-08559.2000
– ident: e_1_2_8_279_1
  doi: 10.1212/WNL.60.1.69
– ident: e_1_2_8_291_1
  doi: 10.1523/JNEUROSCI.0234-12.2012
– volume: 32
  year: 2017
  ident: e_1_2_8_138_1
  article-title: Motor complications in Parkinson's disease: molecular and electrophysiological mechanisms of dyskinesias
  publication-title: Mov Disord
– ident: e_1_2_8_152_1
  doi: 10.1001/archneur.64.7.990
– ident: e_1_2_8_72_1
  doi: 10.1001/jamaneurol.2013.172
– ident: e_1_2_8_137_1
  doi: 10.1002/mds.26714
– ident: e_1_2_8_202_1
  doi: 10.3389/fnhum.2011.00179
– ident: e_1_2_8_239_1
  doi: 10.1002/ana.24648
– ident: e_1_2_8_18_1
  doi: 10.1002/mds.26424
– ident: e_1_2_8_83_1
  doi: 10.1073/pnas.0605208103
– ident: e_1_2_8_67_1
  doi: 10.1016/S1474-4422(09)70238-8
– ident: e_1_2_8_33_1
  doi: 10.1038/nrneurol.2016.196
– ident: e_1_2_8_110_1
  doi: 10.1093/brain/awh607
– ident: e_1_2_8_280_1
  doi: 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q
– ident: e_1_2_8_244_1
  doi: 10.1212/WNL.0b013e318278fe32
– ident: e_1_2_8_57_1
  doi: 10.1176/appi.ajp.2011.10111669
– ident: e_1_2_8_216_1
  doi: 10.1002/mds.26209
– ident: e_1_2_8_45_1
  doi: 10.1002/mds.26263
– ident: e_1_2_8_157_1
  doi: 10.1002/mds.26527
– ident: e_1_2_8_236_1
  doi: 10.1002/mds.26591
– ident: e_1_2_8_249_1
  doi: 10.1016/j.tips.2009.12.006
– ident: e_1_2_8_294_1
  doi: 10.1073/pnas.1300822110
– ident: e_1_2_8_41_1
  doi: 10.1212/WNL.47.1.1
– ident: e_1_2_8_115_1
  doi: 10.1097/01.WCB.0000126563.85360.75
– ident: e_1_2_8_73_1
  doi: 10.1007/s00401-011-0852-9
– ident: e_1_2_8_238_1
– ident: e_1_2_8_16_1
  doi: 10.1136/jnnp.52.Suppl.11
– ident: e_1_2_8_43_1
  doi: 10.1136/jnnp-2014-309645
– ident: e_1_2_8_49_1
  doi: 10.1212/WNL.0b013e31827deb74
– ident: e_1_2_8_243_1
  doi: 10.1038/42166
– ident: e_1_2_8_92_1
  doi: 10.1002/mds.25255
– ident: e_1_2_8_59_1
  doi: 10.1002/mds.26432
– ident: e_1_2_8_132_1
  doi: 10.1007/s11910-014-0501-5
– ident: e_1_2_8_142_1
  doi: 10.1016/S0079-6123(03)43043-4
– ident: e_1_2_8_39_1
  doi: 10.1212/WNL.0b013e31827f0fd1
– ident: e_1_2_8_212_1
  doi: 10.1101/cshperspect.a009258
– ident: e_1_2_8_213_1
  doi: 10.1212/WNL.0000000000000653
– ident: e_1_2_8_158_1
  doi: 10.1038/nrn.2016.13
– ident: e_1_2_8_99_1
  doi: 10.1093/brain/awt172
– ident: e_1_2_8_61_1
  doi: 10.1001/archneurol.2010.65
– ident: e_1_2_8_35_1
  doi: 10.1002/mds.26721
– ident: e_1_2_8_191_1
  doi: 10.3171/jns.1959.16.1.0032
– ident: e_1_2_8_77_1
  doi: 10.1038/1801200a0
– ident: e_1_2_8_123_1
  doi: 10.1212/WNL.0b013e3182315259
– ident: e_1_2_8_198_1
  doi: 10.1093/brain/awv215
– ident: e_1_2_8_65_1
  doi: 10.1002/mds.26102
– ident: e_1_2_8_218_1
  doi: 10.1093/hmg/ddv236
– ident: e_1_2_8_140_1
  doi: 10.1093/brain/awq301
– ident: e_1_2_8_174_1
  doi: 10.1212/WNL.0000000000002509
– ident: e_1_2_8_160_1
  doi: 10.1016/j.neuron.2004.11.005
– ident: e_1_2_8_237_1
  doi: 10.1212/WNL.0000000000000960
– ident: e_1_2_8_104_1
  doi: 10.1002/mds.26662
– ident: e_1_2_8_185_1
  doi: 10.3171/jns.1992.76.1.0053
– ident: e_1_2_8_133_1
  doi: 10.1016/S0303-8467(03)00058-1
– ident: e_1_2_8_164_1
  doi: 10.1016/j.ajhg.2011.06.008
– ident: e_1_2_8_278_1
  doi: 10.1016/S0006-8993(97)01495-9
– ident: e_1_2_8_154_1
  doi: 10.1002/mds.25076
– ident: e_1_2_8_284_1
  doi: 10.1016/S1474-4422(08)70065-6
– ident: e_1_2_8_32_1
  doi: 10.1002/ana.24664
– ident: e_1_2_8_131_1
  doi: 10.1093/brain/awh445
– ident: e_1_2_8_150_1
  doi: 10.1016/j.envint.2014.11.002
– ident: e_1_2_8_204_1
  doi: 10.1016/j.neuroimage.2012.01.088
– ident: e_1_2_8_122_1
  doi: 10.1038/jcbfm.1984.74
– ident: e_1_2_8_47_1
  doi: 10.1136/jnnp-2013-305888
– ident: e_1_2_8_186_1
  doi: 10.1111/j.1600-0447.1960.tb07606.x
– ident: e_1_2_8_60_1
  doi: 10.1016/S0140-6736(13)62106-6
– ident: e_1_2_8_162_1
  doi: 10.1016/S1474-4422(08)70117-0
– volume: 44
  start-page: 870
  issue: 6
  year: 2003
  ident: e_1_2_8_129_1
  article-title: Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I‐beta‐CIT SPECT
  publication-title: J Nucl Med
– ident: e_1_2_8_256_1
  doi: 10.1038/npp.2008.161
– ident: e_1_2_8_240_1
  doi: 10.1016/S1474-4422(16)00080-6
– ident: e_1_2_8_254_1
  doi: 10.1586/ern.12.47
– ident: e_1_2_8_38_1
  doi: 10.1002/mds.26450
– ident: e_1_2_8_235_1
  doi: 10.1212/WNL.0b013e31820f2d79
– ident: e_1_2_8_9_1
  doi: 10.5962/bhl.title.131022
– ident: e_1_2_8_118_1
  doi: 10.1002/ana.410420508
– ident: e_1_2_8_155_1
  doi: 10.1089/jcr.2014.0028
– ident: e_1_2_8_130_1
  doi: 10.1212/WNL.0b013e3181feb2ab
– ident: e_1_2_8_40_1
  doi: 10.1212/01.wnl.0000324625.00404.15
– ident: e_1_2_8_283_1
  doi: 10.1016/j.neurobiolaging.2012.07.018
– ident: e_1_2_8_289_1
  doi: 10.1371/journal.pone.0012122
– ident: e_1_2_8_11_1
  doi: 10.1002/mds.870050213
– ident: e_1_2_8_220_1
  doi: 10.1016/S1474-4422(13)70047-4
– ident: e_1_2_8_98_1
  doi: 10.1212/WNL.0000000000000592
– ident: e_1_2_8_153_1
  doi: 10.1002/ana.20915
– ident: e_1_2_8_26_1
  doi: 10.1093/brain/awm142
– ident: e_1_2_8_219_1
  doi: 10.1002/mds.24051
– ident: e_1_2_8_258_1
  doi: 10.1016/j.tins.2007.03.009
– ident: e_1_2_8_28_1
  doi: 10.1002/mds.26510
– ident: e_1_2_8_208_1
  doi: 10.1126/science.3059497
– ident: e_1_2_8_276_1
  doi: 10.1002/mds.25344
– ident: e_1_2_8_287_1
  doi: 10.3389/fnins.2016.00012
– ident: e_1_2_8_70_1
  doi: 10.1016/j.parkreldis.2015.12.008
– ident: e_1_2_8_169_1
  doi: 10.1002/mds.26521
– ident: e_1_2_8_161_1
  doi: 10.1093/brain/awh676
– ident: e_1_2_8_201_1
  doi: 10.1002/mds.23468
– ident: e_1_2_8_257_1
  doi: 10.1074/jbc.R112.410530
– ident: e_1_2_8_295_1
  doi: 10.1093/brain/awu020
– ident: e_1_2_8_171_1
  doi: 10.1001/archneur.1969.00480160015001
– ident: e_1_2_8_251_1
  doi: 10.1002/mds.26966
– ident: e_1_2_8_94_1
  doi: 10.1002/mds.26201
– ident: e_1_2_8_272_1
  doi: 10.1056/NEJM198911163212004
– ident: e_1_2_8_27_1
  doi: 10.1002/mds.26657
– ident: e_1_2_8_75_1
  doi: 10.1016/S0197-4580(02)00065-9
– ident: e_1_2_8_194_1
  doi: 10.1002/mds.26599
– ident: e_1_2_8_206_1
  doi: 10.1002/mds.10140
– ident: e_1_2_8_263_1
  doi: 10.1002/mds.23795
– ident: e_1_2_8_226_1
  doi: 10.1002/mds.26723
– ident: e_1_2_8_13_1
  doi: 10.1002/mds.870120638
– ident: e_1_2_8_165_1
  doi: 10.1002/mds.25844
– ident: e_1_2_8_84_1
  doi: 10.1126/science.1227157
– ident: e_1_2_8_76_1
  doi: 10.1002/mds.26421
– volume-title: Lectures on the Diseases of the Nervous System, Delivered at La Salpêtrière
  year: 1877
  ident: e_1_2_8_15_1
– volume: 149
  start-page: 175
  issue: 3
  year: 1993
  ident: e_1_2_8_188_1
  article-title: [Effects of the stimulation of the subthalamic nucleus in Parkinson disease]
  publication-title: Rev Neurol (Paris)
– ident: e_1_2_8_189_1
  doi: 10.1126/science.140.3565.394
– ident: e_1_2_8_292_1
  doi: 10.1016/j.biopsych.2015.08.013
– ident: e_1_2_8_119_1
  doi: 10.1212/WNL.0b013e31821ccce4
– ident: e_1_2_8_125_1
  doi: 10.1212/01.wnl.0000326146.60732.d6
– ident: e_1_2_8_116_1
  doi: 10.1093/brain/awh290
– ident: e_1_2_8_274_1
  doi: 10.1001/jamaneurol.2013.5528
– ident: e_1_2_8_42_1
  doi: 10.1002/mds.26054
– ident: e_1_2_8_241_1
  doi: 10.1371/journal.pone.0133863
– ident: e_1_2_8_2_1
  doi: 10.1016/S0072-9752(07)83005-3
– ident: e_1_2_8_107_1
  doi: 10.1093/brain/awt360
– ident: e_1_2_8_37_1
  doi: 10.1002/mds.26018
– ident: e_1_2_8_78_1
  doi: 10.1016/0014-2999(68)90164-7
– ident: e_1_2_8_87_1
  doi: 10.1016/j.tins.2016.09.003
– ident: e_1_2_8_224_1
  doi: 10.1002/mds.24985
– ident: e_1_2_8_266_1
  doi: 10.1016/j.neuron.2011.08.033
– ident: e_1_2_8_54_1
  doi: 10.1056/NEJMoa041470
– volume: 44
  start-page: 445
  year: 1940
  ident: e_1_2_8_182_1
  article-title: Surgical procedure for postencephalitic tremor, with notes on the physiology of the premotor fibers
  publication-title: Arch Neurol Psychiatry
– ident: e_1_2_8_63_1
  doi: 10.1001/archneurol.2009.294
– ident: e_1_2_8_180_1
  doi: 10.1002/ana.410390107
– ident: e_1_2_8_192_1
  doi: 10.1016/S1474-4422(13)70048-6
– ident: e_1_2_8_245_1
  doi: 10.1212/01.wnl.0000306697.48738.b6
– ident: e_1_2_8_265_1
  doi: 10.1073/pnas.0908005106
– ident: e_1_2_8_108_1
  doi: 10.1016/j.tins.2009.06.003
– ident: e_1_2_8_199_1
  doi: 10.1016/0140-6736(92)90457-E
– ident: e_1_2_8_255_1
  doi: 10.1038/nrn.2016.178
– ident: e_1_2_8_85_1
  doi: 10.1002/ana.24066
– ident: e_1_2_8_297_1
  doi: 10.1016/S1474-4422(15)00227-6
– ident: e_1_2_8_51_1
  doi: 10.1002/mds.26431
– ident: e_1_2_8_126_1
  doi: 10.1136/jnnp.2007.127878
– ident: e_1_2_8_261_1
  doi: 10.1016/j.pneurobio.2015.09.012
– ident: e_1_2_8_56_1
  doi: 10.1212/WNL.0b013e3182516244
– ident: e_1_2_8_127_1
  doi: 10.1002/mds.26815
– ident: e_1_2_8_264_1
  doi: 10.1073/pnas.0903691106
– ident: e_1_2_8_205_1
  doi: 10.1016/j.neuroimage.2010.09.028
– ident: e_1_2_8_193_1
  doi: 10.1056/NEJMoa1600159
– ident: e_1_2_8_124_1
  doi: 10.2967/jnumed.111.089946
– ident: e_1_2_8_135_1
  doi: 10.1016/0166-2236(90)90110-V
– ident: e_1_2_8_273_1
  doi: 10.1056/NEJMoa0809335
– ident: e_1_2_8_281_1
  doi: 10.1126/science.290.5492.767
– ident: e_1_2_8_80_1
  doi: 10.1126/science.276.5321.2045
– ident: e_1_2_8_268_1
  doi: 10.1002/mds.25020
– ident: e_1_2_8_228_1
  doi: 10.1002/ana.24385
– ident: e_1_2_8_29_1
  doi: 10.1371/journal.pone.0070244
– ident: e_1_2_8_248_1
  doi: 10.1080/15216540152845939
– ident: e_1_2_8_88_1
  doi: 10.1002/mds.26332
– ident: e_1_2_8_167_1
  doi: 10.1016/j.expneurol.2015.02.020
– ident: e_1_2_8_64_1
  doi: 10.1017/S0317167100010209
– ident: e_1_2_8_86_1
  doi: 10.1016/j.neuron.2011.06.003
– ident: e_1_2_8_187_1
  doi: 10.1002/mds.26636
– ident: e_1_2_8_46_1
  doi: 10.1007/s00415-012-6745-6
– ident: e_1_2_8_293_1
  doi: 10.1002/ana.23614
– volume-title: Hunterian Reminiscences; Being the Substance of a Course of Lectures on the Principles and Practice of Surgery, Delivered by J. Hunter, in the Year 1785
  year: 1833
  ident: e_1_2_8_3_1
– ident: e_1_2_8_112_1
  doi: 10.1002/ana.410340304
– ident: e_1_2_8_210_1
  doi: 10.1038/23281
– ident: e_1_2_8_252_1
  doi: 10.1038/nm1747
– ident: e_1_2_8_52_1
  doi: 10.1212/WNL.56.6.730
– ident: e_1_2_8_66_1
  doi: 10.1093/brain/awu193
– ident: e_1_2_8_298_1
  doi: 10.1016/S0140-6736(14)61010-2
– ident: e_1_2_8_79_1
  doi: 10.1126/science.6823561
– volume: 8
  start-page: 59
  year: 1817
  ident: e_1_2_8_12_1
  article-title: Editor's note
  publication-title: Lond Med Repository
– ident: e_1_2_8_53_1
  doi: 10.1002/mds.24893
– ident: e_1_2_8_246_1
  doi: 10.1002/mds.26562
– ident: e_1_2_8_30_1
  doi: 10.1001/jamaneurol.2015.0703
– ident: e_1_2_8_106_1
  doi: 10.1212/WNL.0b013e3181f11c1d
– ident: e_1_2_8_181_1
  doi: 10.1002/mds.870070204
– volume-title: The Villager's Friend and Physician
  year: 1804
  ident: e_1_2_8_4_1
– ident: e_1_2_8_58_1
  doi: 10.1002/mds.22839
– ident: e_1_2_8_62_1
  doi: 10.1002/mds.26890
– ident: e_1_2_8_242_1
  doi: 10.1126/science.1090278
– ident: e_1_2_8_195_1
  doi: 10.1002/mds.870131303
– ident: e_1_2_8_277_1
  doi: 10.1016/j.expneurol.2014.03.011
– ident: e_1_2_8_267_1
  doi: 10.1002/ana.24098
SSID ssj0011516
Score 2.6810465
SecondaryResourceType review_article
Snippet ABSTRACT This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he...
This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he described...
This article reviews and summarizes 200 years of Parkinson’s disease. It comprises a relevant history of Dr. James Parkinson’s himself and what he described...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1264
SubjectTerms 200 years anniversary
Anniversaries and Special Events
History, 19th Century
History, 20th Century
History, 21st Century
Humans
Movement disorders
Neurodegenerative diseases
Paralysis
Parkinson Disease - history
Parkinson's disease
Shaking Palsy
Title Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.27115
https://www.ncbi.nlm.nih.gov/pubmed/28887905
https://www.proquest.com/docview/1936787246
https://www.proquest.com/docview/1937531778
https://pubmed.ncbi.nlm.nih.gov/PMC5685546
Volume 32
WOSCitedRecordID wos000412293000059&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1531-8257
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0011516
  issn: 0885-3185
  databaseCode: DRFUL
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7Rpap6KX1BFyhyq0rtgUDiOLEDp1XpqgdAqBRpb5EfsRaJJogsSPx7xnY2ZQVIlXqL5Inj2DOZzxnPNwBfhJAaXYeOYpsUEcsoi1RiGQI5U0heJYVUnsT1kB8fi8mkOFmC_XkuTOCH6H-4Ocvw32tn4FK1u39JQ_-YdofyxCWYL1PU22wAywe_xmeHfRABnVkeQGTmk4TnxEIx3e1vXnRHDzDmw6OS9yGs90Hjlf8a_Wt41UFPMgq68gaWqvotvDjqguvvoDmR7WybXIaEpG0ia0MC5QhpLHHp0T5T7GtLuqjOHhmRNtSvJ66Syi1paoKAkqBNzKZkVIdDHzhI14FrOJ364lfY2UV7-x7Oxj9-f_8ZdfUYIo2wIouMrJQwMhUyxY0Qy3NqtDW8kKxIdc4tgk1LTcYSm-lY44orlVQ6VWlsK2m5TVdhUDd19QGIjWXuWHFTEWuWqFS48KbR2IdihYrpEL7Nl6XUHVm5q5lxUQaaZVriBJZ-AofwuRe9DAwdjwltzte27Iy0LRG7oqvmlOVD-NQ3o3m5mImsq-bay-CGLuFcDGEtqEL_FCrwC13E2DlfUJJewFF3L7bU51NP4Z3l_nggvqZXkqcHXh4dnPqL9X8X3YCX1IEPfxJuEwazq-vqIzzXN7Pz9moLnvGJ2Ops5Q7S2hat
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEB9KK-pL61fb06qrCPrQtMlmk90UXw7rUfHuKLaFvoX9yHKFmpTmKvS_d3Y3Fz2qIPgW2Mlmk53J_HZn5zcA74SQGl2HjmKbFBHLKItUYhkCOVNIXiWFVJ7EdcynU3F-XhyvwMdFLkzgh-g33Jxl-P-1M3C3Ib3_izX0u2n3KE9chvkaQzVC_V47_DY6G_dRBPRmeUCRmc8SXjALxXS_v3nZH90BmXfPSv6OYb0TGm383_AfwXoHPskwaMtjWKnqJ3B_0oXXn0JzLNv5LrkKKUm7RNaGBNIR0ljiEqR9rtj7lnRxnQMyJG2oYE9cLZVb0tQEISVBq5jPyLAOxz5wlK4D13Ay8-WvsLPL9vYZnI0-n346irqKDJFGYJFFRlZKGJkKmeJSiOU5NdoaXkhWpDrnFuGmpSZjic10rHHOlUoqnao0tpW03KabsFo3dbUNxMYyd7y4qYg1S1QqXIDTaOxDsULFdAAfFvNS6o6u3FXNuCwD0TIt8QOW_gMO4G0vehU4Ov4ktLOY3LIz07ZE9IrOmlOWD-BN34wG5qImsq6aGy-DS7qEczGAraAL_VOowH90EWPnfElLegFH3r3cUl_MPIl3lvsDgviaXkv-PvBycnjiL57_u-hreHB0OhmX4y_Try_gIXV7BH7naAdW59c31Uu4p3_ML9rrV53J_ATiLBms
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED9NHZp4YXzTMcAgJHhYtsRxYgfxUlEqEF1VMSbtLXL8oU4aSbV0SPvvOdtpoBpISLxF8sVxbF_u59zd7wBeCyEVmg4VxTYpIpZRFlWJZQjkdCG5SQpZeRLXKZ_NxNlZMd-C9-tcmMAP0f9wc5rhv9dOwc1S26NfrKHfdXtIeeIyzLeZKyIzgO3x18nptPcioDXLA4rMfJbwmlkopkf9zZv26AbIvBkr-TuG9UZosvt_w78LdzrwSUZht9yDLVPfh53jzr3-AJq5bFcHZBlSkg6IrDUJpCOkscQlSPtcsTct6fw678iItKGCPXG1VK5JUxOElAS1YrUgozqEfeAoXQeu4WThy19hZxft9UM4nXz89uFT1FVkiBQCiyzS0lRCy1TIFI9CLM-pVlbzQrIiVTm3CDct1RlLbKZihWteVYlRaZXG1kjLbfoIBnVTmydAbCxzx4ubilixpEqFc3BqhX1UrKhiOoS363UpVUdX7qpmXJSBaJmWOIGln8AhvOpFl4Gj409C--vFLTs1bUtEr2isOWX5EF72zahgzmsia9NceRk80iWciyE8DnuhfwoV-I0uYuycb-ySXsCRd2-21OcLT-Kd5T5AEF_T75K_D7w8Hp_4i71_F30BO_PxpJx-nn15CrepQyI-LG4fBqvLK_MMbqkfq_P28nmnMT8BSi0ZMA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Past%2C+present%2C+and+future+of+Parkinson%27s+disease%3A+A+special+essay+on+the+200th+Anniversary+of+the+Shaking+Palsy&rft.jtitle=Movement+disorders&rft.au=Obeso%2C+J+A&rft.au=Stamelou%2C+M&rft.au=Goetz%2C+C+G&rft.au=Poewe%2C+W&rft.date=2017-09-01&rft.eissn=1531-8257&rft.volume=32&rft.issue=9&rft.spage=1264&rft_id=info:doi/10.1002%2Fmds.27115&rft_id=info%3Apmid%2F28887905&rft.externalDocID=28887905
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon